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Proper neural circuit development, organization, and function are 
essential to produce correctly executed behaviors. Neural circuits in the spinal 
cord process sensory information, and coordinate movement. One essential 
circuit in the spinal cord that has been well studied is the sensory-motor reflex 
circuit. This circuit is subject to interneuron modulation, specifically by 
inhibitory GABAergic interneurons, termed GABApre neurons. GABApre 
neurons exert presynaptic inhibition by forming synaptic boutons on sensory 
afferent terminals and thereby controlling sensory signaling onto motor 
neurons.  
Previous work on GABApre neurons has identified that they express 
specific synaptic markers, possess stringent specificity with their sensory 
neuron synaptic partner, and play a role in mediating smooth movement. 
Deficits in presynaptic inhibition have been observed in human diseases, such 
as dystonia and Parkinson’s disease. GABApre neurons exert presynaptic 
inhibition but their molecular profile and contribution to motor disease is not 
well known. 
In this dissertation, I examine the molecular profile of GABApre 
neurons, and their potential link to the motor disease, dystonia. I show that the 
 kelch-like family member 14 (Klhl14) identified from a screen for genes 
enriched in the intermediate spinal cord, is expressed in GABApre neurons. 
Klhl14 directly binds the torsin family 1, member A (Tor1a) dystonia protein, 
which is co-expressed in GABApre neurons. Further, I show that when Tor1a 
is mutated in such a way that disrupts its binding with Klhl14, there is a 
reduction in the number of properly formed GABApre boutons, providing a link 
between GABApre circuitry and motor disease. 
 
  iii 
BIOGRAPHICAL SKETCH 
 
Juliet Zhang graduated with a BA in Philosophy and minor in Natural 
Sciences from the University of Southern California in Los Angeles, CA in 
2008. She was first exposed to an interest in neuroscience when she was a 
Research Assistant in the laboratory of Dr. Nathaniel Heintz at Rockefeller 
University in New York, NY from 2008 to 2010 before she enrolled in the 
Neuroscience PhD program at Weill Cornell Graduate School of Medical 
Sciences. Juliet was born in China, and raised in Canada before moving to the 
United States when she was 12.  
 
  iv 
DEDICATION 
 
To Damion, for always being with me through the most informative years of my 
life. I miss you. 
 
To Mom, for always being supportive of my dreams no matter how ambitious, 
and always fostering my creative and artistic side. 
 




  v 
ACKNOWLEDGEMENTS 
Firstly, I would like to thank Dr. Julia A. Kaltschmidt for the being my 
graduate mentor and giving me the opportunity to conduct this work in her lab. 
Julia’s guidance, attention, and compassion have been major assets towards 
both conducting research and writing throughout the entirety of my PhD. She 
has always impressed upon me her dedication and hard work. I would also like 
to thank past and present members of the lab- Jarret Weinrich for the screen 
for intermediate enriched genes, contributions to synaptic analyses, discussion 
on dystonia and helpful advice, Josephine Belluardo for technical assistance, 
helpful discussion and encouragement, Richard DiCasoli for technical 
assistance and always being willing to help, Danny Comer for data analysis, 
discussion on developmental timing and sharing wisdom, Praveen 
Bommareddy for technical assistance and being supportive, Aanchal Tyagi for 
technical assistance, and Jeff Russ for preliminary timing data. I would like to 
thank the Bioinformatics core at MSKCC for data analysis. I am very grateful 
to my thesis committee- Dr. M. Elizabeth Ross, Dr. Tao Sun, and Dr. Leslie B. 
Vosshall- for their guidance and encouragement throughout my graduate 
training.   
 Finally, I want to thank my parents and family for all the love and 
support, and always believing in my success. I want to thank Brian Haley for 
being an amazing partner in every which way imaginable. I also want to thank 
all my friends- both human and cat friends alike- having such a close 
community has always been invaluable. 
  vi 
TABLE OF CONTENTS 
Biographical Sketch ............................................................................................... iii	  
Dedication ............................................................................................................ iv	  
Acknowledgements ............................................................................................... v	  
Table of Contents ................................................................................................. vi	  
List of Figures ...................................................................................................... viii	  
List of Abbreviations ............................................................................................. ix	  
List of Symbols ..................................................................................................... xi	  
 
Chapter 1: Spinal motor circuit assembly and potential role in motor 
disease ................................................................................................................. 1	  
1.1 Introduction ...................................................................................................... 1	  
1.2 Motor neuron organization .............................................................................. 1	  
1.2.1 Motor neuron development .......................................................................... 3	  
1.3 Sensory neuron development ......................................................................... 7	  
1.4 Sensory-motor reflex circuit ............................................................................. 8	  
1.5 Interneuronal diversity and development ...................................................... 12	  
1.6 Temporal regulation contributes to interneuron identity ................................ 13	  
1.7 Premotor interneuron circuitry ....................................................................... 15	  
1.8 Presynaptic inhibitory interneurons and gain control ..................................... 15	  
1.8.1 Molecular and cellular identity of GABApre neurons .................................. 17	  
1.8.2 Synaptic specificity of GABApre neurons ................................................... 21	  
1.9 Motor diseases in humans involving presynaptic inhibition ........................... 22	  
1.9.1 Dystonia ..................................................................................................... 25	  
1.9.2 Tor1a and Klhl14 binding ........................................................................... 27	  
 
Chapter 2:	   Screen for specific GABAergic subgroups identifies role for 
Dystonia-associated genes in spinal circuitry ............................................... 29	  
2.1 Author Contributions ...................................................................................... 30	  
2.2 Acknowledgements ....................................................................................... 30	  
2.3 Abstract ......................................................................................................... 31	  
2.4 Significance Statement .................................................................................. 32	  
2.5 Introduction .................................................................................................... 32	  
2.6 Materials and Methods .................................................................................. 35	  
2.6.1 Mouse Strains ............................................................................................ 35	  
2.6.2 Tamoxifen Injections .................................................................................. 35	  
2.6.3 Histochemistry ............................................................................................ 36	  
2.6.4 Synaptic Quantification ............................................................................... 37	  
2.6.5 Candidate Screen ....................................................................................... 37	  
2.6.6 Statistics ..................................................................................................... 37	  
2.7 Results .......................................................................................................... 38	  
 2.7.1 Screen for motor disease associated markers enriched in the 
intermediate spinal cord ...................................................................................... 38	  
2.7.2 Klhl14 is expressed in intermediate inhibitory interneurons ....................... 41	  
2.7.3 Late but not early Ptf1a expression distinguishes GABApre neurons ........ 43	  
2.7.4 Klhl14 is expressed in GABApre neurons .................................................. 47	  
2.7.5 GABApre bouton formation is disrupted in Tor1a mutant mice .................. 47	  
2.8 Discussion ..................................................................................................... 52	  
2.8.1 Molecular characterization and transcriptional screening of GABApre 
neurons ............................................................................................................... 53	  
2.8.2 Tor1a function in GABApre circuitry ........................................................... 54	  
2.8.3 Where is Tor1a functioning to affect GABApre synaptogenesis? .............. 55	  
2.8.4 Tor1a in GABAergic synaptogenesis ......................................................... 56	  
 
Chapter 3: Developmental Timing and Candidate Genes of GABApre 
neurons .............................................................................................................. 58	  
3.1 Introduction .................................................................................................... 58	  
3.2 Identity of early Ptf1a-derived interneurons ................................................... 58	  
3.3 Novel GABApre interneuron genes ............................................................... 61	  
 
Chapter 4: Concluding Remarks and Future Directions ............................... 69	  
4.1 Introduction .................................................................................................... 69	  
4.2 Timing of neurogenesis of Ptf1a-derived interneurons .................................. 70	  
4.3 Disrupted Klhl14 and Tor1a binding due to Dyt1ΔE mutation ....................... 72	  
4.4 Analysis of a Klhl14 mutant ........................................................................... 75	  
4.5 Descending pathways in dystonia ................................................................. 78	  
4.6 Behavioral testing and function ..................................................................... 81	  
4.7 Concluding remarks ...................................................................................... 83	  
 
References ......................................................................................................... 85	  
 
 
  viii 
LIST OF FIGURES 
 
Figure 1.1 Motor neuron organization………………………………………….....4 
Figure 1.2 Ventral progenitor domains………………………………………..…..6 
Figure 1.3 Major classes of sensory neurons…………………………………….9 
Figure 1.4 The monosynaptic reflex circuit……………………………………...11 
Figure 1.5 GABApre interneuron function……………………………………….18 
Figure 1.6 GABApre bouton molecular identification…………………………..20 
Figure 1.7 H-reflex as a measure of presynaptic inhibition……………………24 
 
Figure 2.1 Screen for novel genes expressed in the intermediate spinal 
cord…………………………………………………………………………….…….40 
Figure 2.2 Klhl14 expression in spinal inhibitory interneurons …………..…...42 
Figure 2.3 Klhl14 is expressed in GABApre neurons ………………………....44 
Figure 2.4 Abnormal GABApre synaptic organization in Dyt1ΔE mice ……..49 
 
Figure 3.1 Synaptic identity of early e9.5 TM labeled synapse…………........64 
Figure 3.2 Targeting of early and late labeled Ptf1a-derived neurons…........66 
Figure 3.3 Tfap2β and Crym expression…………..........................................69 
Figure 3.4 Timing of Tfap2β expression in Ptf1a-derived cells ……………....72 
 
Figure 4.1 Timeline of Ptf1a expression………………………………………...60 
Figure 4.2 Using BrdU to assign timing of birth to Ptf1a-derived neurons......62 
Figure 4.3 Mouse lines to better study Klhl14 expression and function ……..76 
 
  ix 
LIST OF ABBREVIATIONS 
 
ATP .............................................................................. adenosine triphosphate 
BMP ...................................................................... bone morphogenetic protein 
BrdU .................................................................................... bromodeoxyuridine 
Caspr4 ......................................................... contactin associated protein-like 4 
Chl1 .......................................................... contactin adhesion molecule L1-like 
Cm ..................................................................................... cutaneous maximus 
CNS .............................................................................. central nervous system 
Cre .......................................................................................... cre recombinase 
CreER ........................................... cre recombinase fused to estrogen receptor 
Crym ............................................................................................. crystallin, mu 
CST ........................................................................................ corticospinal tract 
Dyt1ΔE ............................................. Tor1a with a single glutamic acid deletion 
DRG ..................................................................................... dorsal root ganglia 
DT ..........................................................................................diphtheria Toxin A 
Dyt1 ........................................... torsin family 1, member A / dystonia 1 protein 
e ................................................................................................. embryonic day 
EM ..................................................................................... electron microscopy 
EPSP ............................................................. excitatory post-synaptic potential 
ER .................................................................................. endoplasmic reticulum 
Er81 ............................................................................................... ets variant 1 
FACS ........................................................... fluorescence-activated cell sorting 
FoxP1 ........................................................................... forkhead homeobox P1 
GABA .................................................................................. γ-aminobutyric acid 
GAD ...................................................................... glutamic acid decarboxylase 
GDNF ................................................. glial cell line-derived neurotrophic factor 
GFP ............................................................................ green fluorescent protein 
HRP ............................................................................. horse radish peroxidase 
IaIN ............................................................................... Ia inhibitory interneuron 
Klhl14 .................................................................... kelch-like family member 14 
KO ....................................................................................................... knockout 
Lbx1 .................................................................................. ladybird homeobox 1 
LMC ................................................................................... lateral motor column 
MN ................................................................................................ motor neuron 
NB2 .................................................................................................. contactin 5 
 NE .......................................................................................... nuclear envelope 
NMJ .............................................................................. neuromuscular junction 
NPY ........................................................................................... neuropeptide Y 
NrCAM ............................................................ neuronal cell adhesion molecule 
p ................................................................................................... postnatal day 
PAD ................................................................... primary afferent depolarization 
Pea3 .............................................................................................. ets variant 4 
pENK ................................................................................................ enkephalin 
PFA ....................................................................................... paraformaldehyde 
Plxnd1 ................................................................................................. plexin D1 
pMN ........................................................................... motor neuron progenitors 
Ptf1a ................................................................ pancreas transcription factor 1a 
Pv ................................................................................................... parvalbumin 
RC................................................................................................. Renshaw cell 
RFP..................................................................................red fluorescent protein 
RT-PCR ............................... reverse transcription Polymerase Chain Reaction 
SD ........................................................................................ standard deviation 
SEM ........................................................................ standard error of the mean 
Sema3e ..................................................................................... semaphorin 3e 
Shh .......................................................................................... sonic hedgehog 
Syt1 ........................................................................................ synaptotagmin-1 
Tfap2β.................................................................. transcription factor AP-2 beta 
Tlx ............................................................................ T-cell leukemia homeobox 
TM ...................................................................................................... tamoxifen 
Tor1a ......................................... torsin family 1, member A / dystonia 1 protein 
Tri ............................................................................................................ triceps 
vGluT1 .......................................................... vesicular glutamate transporter-1 
wt ......................................................................................................... wild-type 
YFP ........................................................................... yellow fluorescent protein  
 
  xi 
LIST OF SYMBOLS 
 
β .................................................................................................................. beta 
Δ ................................................................................................................ delta 
γ ............................................................................................................. gamma 
μ ................................................................................................................ micro 










  1 
Chapter 1 
 
Spinal motor circuit assembly and potential role in motor disease 
 
1.1 Introduction 
The ability of an organism to acquire information, process it, and 
interact successfully with its environment is dependent on the proper 
functioning of its central nervous system (CNS). The CNS consists of the brain 
and spinal cord, which relay information through neural circuits and synapses. 
In order for neural circuitry to wire correctly, an extremely high level of 
organization and precision is required. Even the slightest perturbation to this 
system can lead to neurological deficits and disease, such as schizophrenia 
and multiple sclerosis.  
In order to understand neurological diseases and determine how to 
ameliorate and cure them, it is essential to first understand how the nervous 
system functions. Understanding neural circuitry formation and how its 
component neurons form synaptic contacts and maintain them is a complex, 
multi-faceted question in neuroscience. Historically, circuits in the spinal cord 
that control motor behavior have served as an excellent system to probe this 
question. 
 
1.2 Motor neuron organization 
 In the spinal cord, three fundamental neuronal classes are essential for 
controlling motor behavior. Motor neurons, sensory neurons and interneurons 
 play unique roles in facilitating movement. Motor neurons form specialized 
synapses called neuromuscular junctions (NMJ) onto muscles. Upon 
neurotransmitter release from the NMJ, the muscle is triggered and movement 
results (Amin et al., 2015).  
Motor neuron cell bodies reside within the ventral spinal cord (ventral 
horn), and their projections extend great distances throughout the organism to 
contact discrete muscles. The positioning and connectivity of motor neurons is 
highly orchestrated and precise. Motor neurons target muscles with distinct 
functions, such as flexors or extensors. Flexor muscles contract and decrease 
the angle of a joint, such as the biceps bending the elbow joint. Extensors 
contract and extend, which increases the angle on a joint, such as the triceps 
straightening the elbow joint. How motor neurons are organized, develop, and 
target distinct muscle groups have been heavily studied topics in 
neuroscience.  
Some of the first work that began to elucidate motor neuron 
organization was performed by George Romanes in 1951 (Romanes, 1951). 
He combined histological visualization and selective muscle denervation to 
explore motor neuron organization and innervation of specific muscles in the 
mammalian hindlimb. By crushing specific nerves in the hindlimb of the cat, he 
was able to trace the nerves back to chromatolytic, or injured, neurons in the 
spinal cord, thereby identifying the position of motor neurons in relation to 
specific muscle innervation (Romanes, 1951). Romanes found that motor 
neurons cluster into functionally related groups, which he named “motor pools” 
(Fig. 1.1A). Motor neurons within a motor pool innervate a single muscle. 
Motor pools are positioned along a finite rostrocaudal extent of the spinal cord, 
 which are called motor columns (Romanes, 1951). The precise positioning of 
these columns within the dorsoventral, mediolateral and rostrocaudal axes of 
the spinal cord topographically corresponds to the location of their targets in 
the periphery (Sürmeli et al., 2011). For example, in the lateral motor column 
(LMC) whose motor neurons innervates limbs, the medial LMC motor neurons 
target the ventral part of a limb and the lateral LMC motor neurons target the 
dorsal part of the limb (Fig. 1.1B, Stifani, 2014). 
More recently, dyes have been used as tracers to backfill motor neuron 
cell bodies from limb muscles. The injection of horseradish peroxidase (HRP) 
into limb muscles retrogradely labels motor neurons, and allows for a clear 
visualization of their cell bodies in the spinal cord. In addition, fluorescent 
signal amplification of such tracers used to backfill motor neurons along with 
immunohistochemistry methods has allowed for a near complete assessment 
of motor pool organization (McHanwell and Biscoe, 1981; Lin et al., 1998; 
Sürmeli et al., 2011).  
 
1.2.1 Motor neuron development 
Neuronal positioning and differentiation in the developing spinal cord is 
directed by two secreted signaling sources, sonic hedgehog (Shh) and bone 
morphogenetic protein (BMP), that form gradients along the dorsoventral axis. 
Shh is expressed ventral-high and dorsal-low, while BMP is expressed 
oppositely, dorsal-high and ventral-low (Jessell, 2000; Liem et al., 2000).  
  
Figure 1.1: Motor neuron organization 
(A) Drawing from George Romanes showing motor neurons organized by 
pool, and extending into columns along the rostrocaudal axis. Functionally 
related motor neurons that innervate the same muscle are clustered together 
in distinct motor pools. From Romanes, 1951. 
(B) Motor neuron positioning in the spinal cord corresponds to motor neuron 
projections in the periphery. In the LMC, lateral motor neurons innervate the 
dorsal part of the limb, whereas the medial motor neurons innervate the 
ventral part of the limb. Adapted from Stifani et al., 2014. 
  
  These inductive signals, followed by the expression of specific homeodomain 
proteins, determine 11 specific progenitor domains that occupy discrete 
dorsoventral positions (Briscoe et al., 2000; Gross et al., 2002; Müller et al., 
2002). Six of these domains are dorsal, and five are ventral (Fig. 1.2, Jessell, 
2000; Alaynick et al., 2011; Zeilhofer et al., 2012). The progenitor domains 
extend throughout the rostrocaudal extent of the organism, and precursors 
within the domains give rise to postmitotic neurons during development. Motor 
neurons require a high concentration of Shh protein to be induced (Roelink et 
al., 1995; Ericson et al., 1996; Liem et al., 2000). The ventral pre-motor neuron 
(pMN) domain gives rise exclusively to motor neuron precursors beginning on 
embryonic (e) day e9.5 (Hollyday and Hamburger, 1977; Nornes and Carry, 
1978). 
Motor neurons begin innervating their muscle targets at e11.5, while 
their cell bodies are grouped in pools and coupled electrically by gap junctions, 
which are intercellular connections that enable cells to share electrical 
impulses and eventually fire together (Chang et al., 1999; Hanson and 
Landmesser, 2003). The timing of motor neurons sending out projections to 
the periphery correlates with the initial expression of the Ets family 
transcription factors in motor neurons. Ets variant 4 (Pea3) is one of these 
factors and is expressed in subsets of motor neurons within the LMC during 
early development (Livet et al., 2002). Pea3 expression is induced by glial cell 
line-derived neurotrophic factor (GDNF) expression in the developing forelimb 
and trunk (Haase et al., 2002). The expression of Pea3 in motor neurons is 
necessary for their proper cell body positioning, and axon targeting and 
branching. In a Pea3 mutant mouse, early neuronal identity is maintained, but   
  
Figure 1.2: Ventral progenitor domains 
Shh protein concentration is graded from the floor plate (FP) and is followed by 
the expression of homeodomain proteins resulting in five progenitor domains. 
V0-V3 domains gives rise to heterogeneous populations of ventral 
interneurons, and the pMN (MN) domain gives rise exclusively to motor 
neurons. From Jessell, 2000.   
 the later steps of motor pool identity are affected. In Pea3 mutant mice, motor 
neurons that usually express Pea3 in the lateral motor column (LMC) shift 
from a ventral position to an abnormal dorsal position. Although axonal 
projections of these mispositioned motor neurons invade the limbs, they fail to 
invade into their muscle target areas and to branch (Livet et al., 2002; 
Vrieseling and Arber, 2006).  
 
1.3 Sensory neuron development 
While motor neurons activate muscles to induce movement, they also 
require proper sensory feedback, which is provided by sensory neurons. 
Sensory neurons are neural crest derived, and their cell bodies reside in the 
dorsal root ganglion (DRG), adjacent to the spinal cord. Sensory neuron 
projections extend into the spinal cord, and to the periphery (Brown, 1981). 
Sensory neurons are born at e10.5 and begin targeting muscles around e12.5, 
following motor neuron generation and targeting (Ozaki and Snider, 1997). 
After targeting the periphery, sensory neurons begin their ingrowth into the 
spinal cord at around e14 (Ladle et al., 2007). 
There are three major classes of sensory neurons: mechanoreceptors, 
nociceptors, and proprioceptors. The different classes of sensory neurons 
communicate different sensory modalities, and participate in distinct neural 
circuits within the spinal cord. Mechanoreceptors sense touch and innervate 
the skin in the periphery, wrapping around hair follicles (Abraira and Ginty, 
2013). They project into the dorsal horn of the spinal cord terminating in the 
deeper laminar layers including layer III, IV, and V. Nociceptors sense 
temperature and pain in the periphery, and project into the dorsal horn where 
 they terminate in superficial laminar layers I and II (Todd, 2010). The third 
class of sensory neurons, proprioceptors, sense the placement of limbs in 
space (Fig. 1.3, Caspary and Anderson, 2003). Two main classes of 
proprioceptors are Ia afferents and Golgi tendon organs (Ib afferents). Ia 
afferents extend projections into the periphery innervating muscle spindles, 
which sense the stretch of the muscle (Brown and Fyffe, 1981), while Ib 
afferents terminate at tendons where they sense muscle tension. The central 
projections of proprioceptors relay information into the spinal cord at two 
termination zones: dorsal projections into lamina V form contacts onto 
interneurons, and ventral projections form contacts onto motor neurons 
(Eccles et al., 1957; Burke and Nelson, 1966; Brown and Fyffe, 1981). 
The developmental timing of when proprioceptive neurons project into 
the spinal cord involves molecular cues from the periphery. By removing the 
hindlimb and therefore neurotrophic factors in the periphery, Ets variant 1 
(Er81), a member of the Ets transcription family is no longer expressed in 
sensory neurons (Lin et al., 1998). This loss of Er81 in proprioceptors leaves 
their dorsal spinal projections intact, but results in the failure of proprioceptors 
to extend ventrally into the spinal cord (Arber et al., 2000). This sensory 
projection phenotype is also recapitulated in Er81 mutant mice, which exhibit a 
severe motor phenotype such as loss of limb control and motor coordination. 
(Arber et al., 2000).  
 
1.4 Sensory-motor reflex circuit 
Proprioceptors and motor neurons together participate in the 
monosynaptic reflex circuit, which contracts a muscle in response to muscle   
  
Figure 1.3: Major classes of sensory neurons 
There are three major classes of sensory neurons: nociceptors, 
mechanoreceptors, and proprioceptors. Sensory neuron cell bodies are 
located in the dorsal root ganglion (DRG), and different classes of neurons 
project into different lamina of the spinal cord. Proprioceptors project into two 
regions of the spinal cord: dorsally in lamina V, and ventrally where 
proprioceptive afferents form contacts onto motor neurons. Adapted from 
Caspary and Anderson, 2003. 
  
 stretch (Fig. 1.4). This simple two-neuron circuit has served as an excellent 
model to understand synaptic specificity. Proprioceptive sensory neurons 
almost exclusively contact motor neurons that project to the same muscle in 
the periphery. This sensory-motor pairing happens less in muscles that have 
the same function (heteronymous muscles), and is almost negligible in 
muscles that have different functions (antagonistic muscles) (Eccles et al., 
1957; Mears and Frank, 1997). 
Different mechanisms have been described to ensure that sensory 
neurons form synapses onto the correct motor neuron partner, and avoid the 
incorrect ones. One way that sensory neurons avoid incorrect motor neuron 
partners is to respond to repellent cues. The motor neurons of the cutaneous 
maximus (Cm) do not receive any direct proprioceptive contacts, and they 
achieve this by expressing a class 3 semaphorin (Sema3e). Sensory neurons 
that express the high-affinity receptor of Sema3e, Plexin D1 (Plxnd1), 
recognize this cue and avoid contacting Cm motor neurons. In Sema3e mutant 
mice, Cm motor neurons do receive proprioceptive input from Ia afferents. 
Furthermore, ectopic expression of Sema3e in the motor neurons of the 
triceps (Tri) that usually receive proprioceptive input greatly reduces the 
number of proprioceptive contacts on them (Pecho-Vrieseling et al., 2009; 
Fukuhara et al., 2013). The proper expression of Sema3e in distinct subsets of 
motor neurons and expression of Plxnd1 in a subset of sensory neurons 
reveals that repulsive molecular cues are essential for proper sensory-motor 
connectivity. 
Besides molecular mechanisms, proper sensory-motor connectivity also 
requires proper cell body positioning of motor neurons in the spinal cord. In   
  
Figure 1.4: The monosynaptic reflex circuit 
The monosynaptic reflex circuit consists of a sensory afferent that forms a 
spindle on a muscle and senses stretch in that muscle, and projects into the 
spinal cord where it forms a terminal on a motor neuron. The motor neuron 
projects back into the same muscle as the sensory neuron. GABApre neurons 
mediate presynaptic inhibition by forming an axo-axonic contact on the 
sensory terminal. Adapted from Betley et al., 2009. 
  
 mutant mice in which motor pool specification is lost due to loss of forkhead 
box P1 (FoxP1), motor neurons have a scrambled cell body positioning. 
Interestingly, the sensory neurons in FoxP1 mutant mice still project to the 
physical location of where specific motor pools should have been and form 
aberrant contacts onto the scrambled motor neurons residing there (Sürmeli et 
al., 2011). Together, these studies suggest that sensory neurons rely on both 
molecular cues as well as motor neuron positioning to find their proper 
synaptic partners.  
 
1.5 Interneuronal diversity and development 
In the spinal cord, interneuron populations span the entire length of the 
spinal cord, and reside in both the dorsal horn as well as the ventral horn. 
Interneurons are extremely heterogeneous and their diversification is reflective 
of the complexity necessary for neural circuits to produce behavior. A major 
goal in neuroscience has been to identify and specifically study 
subpopulations of interneurons throughout the CNS (Jankowska, 2001; 
Zeilhofer et al., 2012; Kepecs and Fishell, 2014).  
How does interneuron diversity arise in the spinal cord? Interneuron 
diversity begins embryonically with three ventral progenitor domains that give 
rise to different classes of ventral interneurons, V0-V3, and six dorsal 
progenitor domains that give rise to different classes of dorsal interneurons, 
dI1-6 (Jessell, 2000; Helms et al., 2005). Each domain gives rise to several 
different neuronal subtypes that express unique sets of transcription factors to 
determine their unique identity (Arber, 2012). For example, the dI4 domain 
expresses pancreas specific transcription factor 1a (Ptf1a) and gives rise to 
 dorsal inhibitory interneurons, whereas the dI5 domain expresses transcription 
factors T-cell leukemia homeobox 1 (Tlx1) and Tlx3 and gives rise to dorsal 
excitatory interneurons (Helms and Johnson, 2003). 
Subpopulations of spinal interneurons can be excitatory or inhibitory, 
primarily using glutamate if excitatory, and γ-aminobutyric acid (GABA) or 
glycine if inhibitory. The acquisition of inhibitory interneuron fate in the dorsal 
spinal cord is necessary and dependent on Ptf1a. Without the expression of 
Ptf1a, interneurons that should have assumed an inhibitory fate, switch to an 
excitatory fate (Glasgow et al., 2005). Excitatory interneuron fate in the dorsal 
spinal cord is dependent on Tlx1 and Tlx3, which suppress GABAergic 
differentiation (Cheng et al., 2004). These opposing transcriptional networks 
suggest that there is a balance between factors that confer inhibitory fates and 
excitatory fates in the spinal cord.  
 
1.6 Temporal regulation contributes to interneuron identity 
Interneurons in the spinal cord are born between e9 to e14.5 (Matise 
and Joyner, 1997; Gross et al., 2002; Müller et al., 2002). The timing of birth of 
interneurons has been used to analyze and differentiate between the eventual 
identities of certain interneuronal subpopulations (Tripodi et al., 2011; Benito-
Gonzalez and Alvarez, 2012).  
In the dorsal spinal cord, ladybird homeobox 1 (Lbx1) is a transcription 
factor expressed in domains dI4-dI6. dI4 and dI5 cells separate into two waves 
of early and late-born interneurons. In early neurogenesis, the dI4 and dI5 
domains are discretely positioned neighboring stripes giving rise exclusively to 
 inhibitory and excitatory neurons respectively. In late neurogenesis dI4 
becomes the new domain dILA, and dI5 becomes the new domain dILB, with 
progenitors occupying the new domains in a salt and pepper fashion. Although 
both early and late cells express the same factor Lbx1, they additionally 
express different transcription factors and have different cell fates (Gross et 
al., 2002; Müller et al., 2002). Timing of birth also contributes to interneuron 
cell fate in the ventral spinal cord. Two types of ventral premotor interneurons 
are Renshaw cells (RC) that mediate recurrent inhibition on motor neurons 
and Ia inhibitory interneurons (IaIN) that mediate reciprocal inhibition on motor 
neurons. While both RCs and IaINs are born from progenitors in the V1 
domain, RCs are born early (e9.5-e10.5) and IaINs are born later (e11.5-
e12.5) (Benito-Gonzalez and Alvarez, 2012; Stam et al., 2012).  
Identifying interneuronal subpopulations by timing of birth has enabled 
analysis of their neuronal circuitry and function. Tripodi et al. (2011) used 
labeling neurons based on timing of neurogenesis to distinguish between 
subpopulations of premotor interneurons. They showed that interneurons that 
form direct contacts with flexor motor neurons have lateral cell body 
positioning in the spinal cord and are born early, at e10.5. Those that contact 
extensor motor neurons have a medial cell body positioning and are born later, 
at e12.5. Tripodi et al. (2011) used a mutant animal in which proprioceptors 
are killed (PvDTA) and both dorsal and ventral termination zones of 
proprioceptors are absent, and found that cell body positioning and 
connectivity of the later born extensor premotor neurons was perturbed, and 
resembled those of the flexor premotor population. In Er81 mutant mice in 
which proprioceptive connectivity is perturbed only in the ventral horn, but not 
 in the dorsal spinal cord, both flexor and extensor premotor interneuron 
distributions remained the same. Taken together, these data show that the 
spatial segregation and projection pattern of a subset of premotor interneurons 
depends on sensory input (Tripodi et al., 2011).  
 
1.7 Premotor interneuron circuitry 
The molecular identity of a specific interneuron is an important factor 
determining which neural circuits the neuron ultimately participates in. Two 
types of premotor neurons that have provided insight into interneuronal 
circuitry are RCs and IaINs. Both cell types are developmentally derived from 
the same lineage in the ventral progenitor domain V1 (Alvarez et al., 2005) 
and form contacts onto motor neurons, however, they participate in different 
neuronal circuits. IaINs form contacts onto antagonistic motor pools, providing 
reciprocal inhibition (Jankowska, 1992), whereas RCs contact synergistic 
motor neurons, providing recurrent inhibition. During development, both RCs 
and IaINs receive direct contacts from group Ia proprioceptive afferents. 
However the direct sensory contacts on RCs are transient, weakening after 
p15; while, those on IaINs strengthen to adulthood (Mentis et al., 2006). RCs 
also receive direct cholinergic input from motor neurons, whereas IaINs do not 
(Alvarez and Fyffe, 2007).  
 
1.8 Presynaptic inhibitory interneurons and gain control 
 The sensory-motor reflex circuit is modulated by a number of different 
interneurons. From the point of view of the sensory-motor reflex circuit, there 
 are two GABAergic subtypes, those that form direct contacts onto motor 
neurons, and those that form axo-axonic contacts onto the sensory terminals 
that contact motor neurons (Frank and Fuortes, 1957; Mears and Frank, 1997; 
Rudomin, P. & Schmidt, 1999; Betley et al., 2009). These latter cells are 
termed GABApre neurons due to their direct contacts with sensory neuron 
terminals, the pre-synaptic neuron in the sensory-motor circuit (Hughes et al., 
2005; Betley et al., 2009), and their expression of GABA. GABApre neurons 
mediate presynaptic inhibition, by attenuating transmitter release onto 
postsynaptic neurons. Presynaptic inhibition occurs throughout the CNS 
(Rudomin, 2009; Kubota et al., 2016). For example in the cortex, Chandelier 
cells are one type of cortical inhibitory interneuron that preferentially forms 
axo-axonic contacts onto the axon initial segment of pyramidal cells (Jiang et 
al., 2015; Kubota et al., 2016). 
 Presynaptic inhibition exerted by GABApre boutons on sensory 
terminals results in primary afferent depolarization (PAD), which causes motor 
neurons to be less likely to fire (Eccles et al., 1961, 1962, 1963). 
Pharmacological studies determined that GABA is the neurotransmitter 
mediating presynaptic inhibition (Eccles et al., 1963), and electron microscopy 
provided anatomical evidence of GABApre boutons on sensory afferent 
terminals (Conradi, 1969). Furthermore, presynaptic inhibition can be 
measured in living organisms by measuring the H-reflex, which is the reflex in 
muscles following electrical stimulation of sensory afferents (Knikou, 2008). 
 What is the function of GABApre neurons and presynaptic inhibition on 
sensory-motor drive? Recent work has shown that presynaptic inhibition is a 
way to modulate the gain of sensory neurons. Fink et al. (2014) found that 
 GABApre neurons are essential for mediating smooth movement of the 
forelimb. Ablating this cell subtype in mice and then subjecting these mice to a 
targeted reaching assay resulted in motor perturbations. Specifically, when 
GABApre-depleted mice attempted to reach for a pellet of food, their forelimb 
moved in an abnormal oscillatory motion and had difficulty grasping the pellet 
(Fig. 1.5). This suggests that GABApre neurons are essential for gating 
sensory gain during movement, and the absence of these cells results in gain 
overload and motor perturbations (Fink et al., 2014). 
 
1.8.1 Molecular and cellular identity of GABApre neurons 
 GABApre neurons have been further characterized cellularly and 
molecularly. GABApre neurons express two specific GABA synthesizing 
enzymes, the glutamic acid decarboxylase (GAD) 67 as well as GAD65 
(Hughes et al., 2005; Betley et al., 2009). GAD67 is localized cytoplasmically 
at the synapse, and is widely expressed in all GABAergic neurons in the spinal 
cord. GAD65 is vesicle bound at the synapse, and is largely restricted to 
GABApre neurons. Furthermore, GABApre boutons also express the synaptic-
vesicle associated protein, Synaptotagmin 1 (Syt1). By using a combination of 
these GABApre synaptic markers, GABApre boutons can be visualized on 
sensory afferent terminals, which can be labeled with the vesicular glutamate 
transporter 1 (vGluT1) (Fig. 1.6). Moreover because GABApre neurons 
express Ptf1a during development, they can be permanently labeled using 
genetic lineage tracing with Ptf1aCre mice intercrossed to a fluorescent reporter 
line. These data provide a toolbox with which to analyze GABApre boutons 
(Betley et al., 2009).   
 Figure 1.5: GABApre interneuron function 
(A) Mice are tested for skilled forelimb movement, in which they reach for a 
pellet of food through a small opening. 
(B) A virus for cre-recombinase dependent diphtheria toxin (DT) is injected into 
the spinal cord of Gad2Cre mice, thereby killing Gad2 expressing cells. 
GABApre boutons are maintained in mice before viral injection (Pre-DT), but 
mostly absent in Gad2Cre mice after viral injection (Post-DT).  
(C) Post-DT mice exhibit significant deficits in reaching for the pellet of food 
(red) when compared to Pre-DT mice (blue). 
(D) Post-DT mice exhibit an abnormal oscillatory motion as their arms reach 
forward. Pre-DT mice reach in a smooth movement forward. These data 
suggest that GABApre neurons mediate smooth movement and gain control 





Figure 1.6: GABApre bouton molecular identification 
(A) GABApre neurons can be colabeled with synaptic markers and form 
boutons on sensory neuron terminals (SN) that can be labeled with vGluT1, 
which contact motor neurons (MN). 
(B-D) GABApre boutons can be labeled with GAD65 (G65), GAD67 (G67), 
and Syt1. Adapted from Betley et al., 2009. 
  
   There have been several lines of evidence suggesting that the 
neuronal source of GABApre neurons is in the intermediate spinal cord. Firstly, 
in a double fluorescent in situ hybridization experiment, Betley et al. (2009) 
observed overlap between Gad1 (the gene for GAD67 expression) and Gad2 
(the gene for GAD65 expression) over a small region in the intermediate spinal 
cord. Since GABApre boutons uniquely express both GAD65 and GAD67, 
these neuronal cell bodies likely correspond to the GABApre population 
(Betley et al., 2009). Secondly, since GABApre projections extend to the 
ventral horn, retrograde labeling was used to trace the location of their cell 
bodies. Dextran, a tracer dye was injected by electrophoresis into the ventral 
horn of mice expressing GFP under the control of the GAD65 promoter 
(GAD65GFP), resulting in a limited number of double-labeled, dextran/GFP 
double-positive cell bodies in the intermediate spinal cord (Hughes et al., 
2005). Finally, electrophysiological data demonstrated that PAD could be 
specifically evoked during stimulation of the intermediate but not the dorsal 
spinal cord (Jankowska et al., 1981). Taken together, these three studies 
highly suggest that GABApre cell bodies reside in the intermediate spinal cord.  
 
1.8.2 Synaptic specificity of GABApre neurons 
 GABApre boutons maintain a stringent specificity for their postsynaptic 
targets. When the sensory afferent synaptic target of GABApre neurons is 
absent, as in Er81-/- mouse mutants, GABApre neurons innervate the ventral 
spinal cord, but do not form synapses on any other possible synaptic targets in 
the ventral horn, and instead retract (Betley et al., 2009).  
  What mediates GABApre synaptic specificity? Since the only 
acceptable synaptic partner of GABApre boutons is sensory neurons, it would 
follow that a sensory-derived signal is responsible for GABApre synaptic 
specificity. Ashrafi et al. (2014) found that the immunoglobin (Ig) superfamily 
protein, contactin 5 (NB2) was co-expressed and interacted with the contactin-
associated protein-like 4 (Caspr4) in proprioceptors. In the absence of one or 
both of these proteins in single and double mutant mice there was a 40% 
reduction in the number of GABApre boutons when compared to wild-type (wt) 
mice. While NB2/Caspr4 promotes GABApre bouton formation on the sensory 
neuron side, two members of the L1 Ig family, cell adhesion molecule L1-like 
(CHL1) and neuronal cell adhesion molecule (NrCAM) are also necessary on 
the GABApre neuron side. Loss of CHL1 and NrCAM in GABApre neurons 
results in a loss of GABApre boutons on sensory afferent terminals. The 
interaction between sensory NB2/Caspr4 and interneuron NrCAM/CHL1 is an 
important, though not sole contributor to the formation of GABApre boutons on 
sensory terminals (Ashrafi et al., 2014a). 
 
1.9 Motor diseases in humans involving presynaptic inhibition 
 In humans, deficits in presynaptic inhibition have been associated with 
several movement disorders such as dystonia, Huntington’s disease, 
Parkinson’s disease, and spasticity (caused by multiple sclerosis, stroke, 
spinal cord injury). By studying changes in the amplitude of the H-reflex in 
humans, potential deficits in presynaptic inhibition can be elucidated. The H-
reflex is a measure of the excitability of motor neurons, which is usually 
measured in the forearm or leg of human subjects. Measuring the H-reflex 
 generates a curve that consists of two phases: the early phase that involves 
the reciprocal Ia inhibitory pathway due to postsynaptic mechanisms, and the 
late phase due to presynaptic inhibition. Differences in H-reflex amplitude 
following a conditioning stimulus can be used as a measure of the amount of 
presynaptic inhibition exerted on sensory afferent terminals. A larger H-reflex 
amplitude is a sign of decreased presynaptic inhibition (Fig. 1.7, Knikou, 
2008). 
Several motor diseases exhibit changes in the H-reflex that suggest a 
deficit in presynaptic inhibition. Both dystonia and Huntington’s patients 
exhibited a larger H-reflex amplitude, and a significant change in the late 
phase of the H-reflex in upper limbs, signifying a deficit in presynaptic 
inhibition compared with normal subjects (Nakashima et al., 1989; Panizza et 
al., 1990; Priori et al., 2000).  
In Parkinson’s disease, major motor abnormalities exhibited by human 
patients are tremors, rigidity, and bradykinesia, which is a slowness of 
movement. Different groups have tested whether these symptoms could be 
tied to changes in presynaptic inhibition in lower limbs by measuring the H-
reflex (Roberts et al., 1994; Morita et al., 2000). Measuring the H-reflex in the 
soleus muscle of human patients with Parkinson’s disease showed deficits in 
presynaptic inhibition. There was no relation between decreased presynaptic 
inhibition and rigidity, but there was a relation between decreased presynaptic 
inhibition and slower walking speed and worsened bradykinesia (Roberts et 
al., 1994; Morita et al., 2000).  
Finally, deficits in presynaptic inhibition as measured by changes in the 
H-reflex were also observed in patients suffering from spasticity, which can   
  
Figure 1.7: H-reflex as a measure of presynaptic inhibition 
(A) The H-reflex measures the excitation of motor neurons, and can be used 
to measure changes of presynaptic inhibition in humans. The H-reflex can be 
measured from the soleus muscle upon conditioning stimuli applied to the 
nerve. From Knikou, 2008. 
(B) Sample trace of electromyographic record of the H-reflex. From Misiaszek, 
2003. 
(C) There is a greater H-reflex size in human patients of dystonia when 
compared to normal humans, indicative of deficits in presynaptic inhibition on 
the sensory-motor circuit and greater activity in motor neurons. Presynaptic 
inhibition is measured from 10-20 ms. From Priori et al., 1995.  
 result from multiple sclerosis, stroke, or other insults to nervous tissue. 
Spasticity is characterized by continuous contraction in certain affected 
muscles and exaggerated jerks, caused by hyperexcitability of the stretch 
reflex (Morita et al., 2001). When compared to normal subjects, spastic 
multiple sclerosis patients have less presynaptic inhibition, which contributes 
to their inability to exert normal motor control (Morita et al., 2001).   
 
1.9.1 Dystonia 
 Dystonia is a heterogeneous movement disorder characterized by 
involuntary sustained muscle contractions affecting one or more parts of the 
body. Dystonia is widely believed to reflect circuit dysfunction due to the 
absence of signs of neurodegeneration in the CNS of affected individuals. It is 
the third most common movement disorder in humans, and can be 
categorized as two types: primary and secondary dystonia. Primary dystonia 
develops spontaneously and is not caused by any previous insult to the body. 
In contrast, secondary dystonia results from an associated disease such as 
brain or spinal cord injury (Breakefield et al., 2008). 
One type of primary dystonia is early-onset generalized dystonia, which 
begins to affect patients in childhood and early adolescence. Although the 
exact etiology of dystonia is not fully understood, there is a strong genetic link 
between early-onset generalized dystonia and genetic mutations. One 
mutation that is highly implicated in early-onset generalized dystonia is a 
mutation in the torsin family 1 protein (Tor1a/Dyt1). Tor1a encodes a protein in 
the adenosine triphosphate (ATP)-ase family that is involved in protein folding 
and trafficking (Breakefield et al., 2008; Charlesworth et al., 2013). Tor1a is 
 primarily localized to the lumen of the endoplasmic reticulum (ER) and the 
nuclear envelope (NE) (Goodchild et al., 2005; Granata et al., 2011). 
Although Tor1a is expressed widely in several types of tissues, there is 
only a clinical manifestation of mutated Tor1a in neural tissue, suggesting that 
Tor1a plays a critical role in neurons (Granata et al., 2009). A common 
autosomal dominant mutation that is responsible for more than 50% of primary 
early-onset dystonia is a single glutamic acid deletion in Tor1a (Dyt1ΔE) 
(Ozelius et al., 1997). Several studies have been conducted to compare 
differences between wt Tor1a and the mutant Tor1a, Dyt1ΔE protein. An 
accumulation of Dyt1ΔE was found in multiple areas in the CNS between the 
NE layers in neurons, forming abnormal perinuclear membranous inclusions, 
which can alter the function of local proteins (Goodchild et al., 2005). 
Compared to wt Tor1a, Dyt1ΔE was unable to interact with itself or wt Tor1a, 
which is important since Tor1a has been found to form a multimeric complex in 
order to exert its enzymatic ATPase function catalyzing ATP into ADP in vitro 
(Pham et al., 2006). Furthermore, Dyt1ΔE showed decreased enzymatic 
function compared to wt protein, likely due to its inability to interact with itself 
(Konakova and Pulst, 2005).  
 Most of the work conducted on understanding dystonia has been 
focused on the brain. Since the Dyt1ΔE mutation is highly implicated in the 
development of dystonia in humans, several groups have recapitulated the 
same genetic mutation in mouse models of dystonia. Mice that are 
heterozygous for Dyt1ΔE are evaluated for behavior as well as molecular and 
cellular changes in the hippocampus, cortex, and cerebellum (Goodchild et al., 
2005; Vanni et al., 2015; Yokoi et al., 2015). These mice exhibited motor 
 abnormalities that included hyperactivity and deficits in beam walking (Dang et 
al., 2005). They also had decreased frequency of spontaneous (s)EPSCs in 
hippocampal slices, suggesting presynaptic release deficits (Yokoi et al., 
2013). The motor deficits and presynaptic release deficits observed in Dyt1ΔE 
mice are comparable to those seen in Tor1a knockdown and knockout (KO) 
animals, suggesting that the Dyt1ΔE mutation is a loss-of-function (Dang et 
al., 2006; Yokoi et al., 2015). More recently, mutant mice in which Tor1a is 
knocked out in cortical regions and the striatum exhibited dystonic behaviors 
more closely aligned with those observed in human dystonia patients. 
Specifically, these mutant mice exhibited trunk twisting and limb clasping 
(Liang et al., 2014; Pappas et al., 2015). 
 
1.9.2 Tor1a and Klhl14 binding 
 How does mutant Tor1a result in dystonic behaviors? Besides being 
able to interact with itself, Tor1a also binds other proteins such as kelch-like 
family member 14 (Klhl14). Tor1a and Klhl14 are coexpressed in neural 
tissues, and colocalize in the ER. They bind as co-factors, and their binding is 
disrupted although not entirely abolished by the human Dyt1ΔE mutation 
(Giles et al., 2009). Klhl14 expression is present in the intermediate spinal 
cord and is Ptf1a dependent (Wildner et al., 2013), which suggests that it may 
be expressed in GABApre neurons. Despite knowledge of Klhl14-Tor1a 
binding, the function of Klhl14 protein in spinal cord circuitry is completely 
unknown. 
 In the next part of my thesis work, I use genetic analysis and 
developmental timing to localize Klhl14 expression in GABApre neurons, and 
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show defects in GABApre circuitry in mice carrying a genetic mutation that is 
linked to the motor disease, dystonia. 
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2.3 Abstract 
Deficits in presynaptic inhibition have been observed in human motor 
diseases such as dystonia. In the spinal cord, a specific subset of dorsal 
inhibitory interneurons called GABApre neurons modulate sensory-motor 
connectivity, and exert presynaptic inhibition on proprioceptive sensory 
afferent terminals in the ventral horn. Genetic markers to identify GABApre 
neurons, and their potential contribution to motor disease are relatively 
unknown. In this study, we find the kelch-like family member 14 Klhl14, which 
is implicated in dystonia through its direct binding with Tor1a, to be a 
expressed in GABApre neurons. Our data uses the timeline of Ptf1a 
expression to localize Klhl14 to late Ptf1a-derived interneurons in the 
intermediate spinal cord, which are GABApre neurons. Furthermore, we 
demonstrate that in a mutant mouse in which Klhl14 and Tor1a binding is 
disrupted, there is a deficiency in the number of properly formed GABApre 
boutons. Our findings suggest a potential contribution of GABApre neurons to 




2.4 Significance Statement 
Neural circuitry dysfunction has been linked to human motor disorders 
such as dystonia, in which patients exhibit deficits in presynaptic inhibition. 
Presynaptic inhibition is essential for proper motor control, and is mediated by 
spinal inhibitory interneurons. The link between spinal interneurons and motor 
disease is not well studied. In this report, we identified kelch-like family 
member 14 (Klhl14) and its cofactor Tor1a to be expressed in GABApre 
neurons. Mutations in Tor1a have been previously linked to dystonia, and we 
observe GABApre circuit deficits in mice mutant for Tor1a. These data provide 
evidence that Klhl14 and Tor1a expression in GABApre neurons is important 
for their synapse formation. 
 
2.5 Introduction 
The specific organization of neuronal circuits is critical for the 
generation of normal animal behavior and such organization depends 
inherently on the precise differentiation and connectivity of component 
neurons. GABAergic inhibitory interneurons play crucial roles in neuronal 
circuits, modulating the excitability or output of nearby neurons in complex 
ways determined by their specific connectivity. In humans, dysfunction of 
inhibitory interneurons is thought to underlie the symptoms of diverse 
disorders such as spinal cord injury and cerebral palsy (Tillakaratne et al., 
2000; Achache et al., 2010), which may in turn affect locomotor symptoms 
associated with these conditions, such as motor deficit, spasticity, and 
impaired voluntary movement (Comi et al., 2005; Achache et al., 2010). Yet 
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while injury or disease-related functional deficits have been identified in 
physiologically-defined spinal circuits, little is known about the potential 
involvement in these conditions of specific, molecularly-defined classes of 
inhibitory spinal interneurons.  
A main circuit of movement control affected in locomotor disorders is 
the monosynaptic stretch reflex circuit, which can be assessed via the human 
H-reflex (Knikou, 2008). In this circuit, input from a peripheral muscle is 
relayed via proprioceptive sensory neuron afferents onto spinal motor 
neurons, which transmit the signal back to the muscle of origin (Eccles et al., 
1957; Mears and Frank, 1997). Activity across this synapse is presynaptically 
modulated by a specific class of GABAergic interneurons, called GABApre 
neurons, which form presynaptic, axo-axonic synapses on sensory afferent 
terminals (Windhorst, 1996; Rudomin, P. & Schmidt, 1999; Betley et al., 2009). 
In our prior work (Betley et al., 2009) we identified and molecularly 
characterized GABApre interneurons. We demonstrated that they express 
Pancreas transcription factor (Ptf) 1a, and that their terminals can be 
visualized with both GABA synthetic enzymes GAD65 and GAD67, as well as 
the Ca2+ sensor Synaptotagmin-1 (Syt1), thus differentiating GABApre 
neurons from other Ptf1a-derived interneurons (Betley et al., 2009). Several 
lines of evidence have suggested GABApre cell bodies to reside in the 
intermediate spinal cord: GAD65 and GAD67 co-express in neuronal cell 
bodies of the intermediate spinal cord (Betley et al., 2009); injection of a tracer 
dye into the ventral motor column to which GABApre neurons project labels 
GAD65-expressing cell bodies in the intermediate spinal cord (Hughes et al., 
2005); and electrical stimulation of the intermediate spinal cord leads to 
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primary afferent depolarization (PAD), considered to be a result of presynaptic 
inhibition (Jankowska et al., 1981). 
Despite our knowledge of the afferent connectivity and molecular profile 
of GABApre interneurons, we know relatively little about the molecular 
strategies used to establish and maintain the specific connections between 
GABApre interneurons and their sensory afferent terminal targets. We further 
know little about what role the GABApre-sensory microcircuit may play in 
disease states, and whether changes in this circuitry may reflect causes of, or 
adaptations to, motor illnesses. Clues to the involvement of GABApre 
interneurons in such illnesses come from physiologic studies showing deficits 
in presynaptic inhibition in people affected by motor diseases. Individuals with 
dystonia, Huntington’s disease, and Parkinson’s disease show larger H-
reflexes in upper limbs, signifying a deficit in presynaptic inhibition (Nakashima 
et al., 1989; Panizza et al., 1990; Roberts et al., 1994; Priori et al., 1995, 2000; 
Morita et al., 2000). However, the specific functional involvement of 
presynaptic inhibitory interneurons in these motor diseases is unknown. 
In this study we used microarray and in silico screening techniques to 
identify a set of transcripts specifically expressed by inhibitory interneurons in 
the intermediate spinal cord. We identified Klhl14 to be expressed in Ptf1a-
derived cells, and used the timeline of Ptf1a expression to localize Klhl14 
expression to GABApre cell bodies in the intermediate spinal cord. To explore 
the consequences of disrupting Klhl14 activity in GABApre interneurons, we 
used a mutant mouse (Dyt1ΔE) in which the binding partner of Klhl14, the 
more broadly expressed Tor1a, is mutated, resulting in a decrease in Klhl14 
and Tor1a binding (Giles et al., 2009). Analysis of Dyt1ΔE mice showed a 
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decrease in GABApre bouton number on sensory afferent terminals, 
suggesting that Klhl14 and Tor1a play a role in GABApre bouton formation. 
Taken together, our findings help define the organization and genetic profile of 
a discrete set of intermediate spinal inhibitory interneurons that exert 
significant modulatory action during motor behavior. Our results suggest a link 
between a genetic lesion and specific circuit level developmental and 
neurophysiological dysfunction. 
 
2.6 Materials and Methods 
2.6.1 Mouse Strains 
The following mouse strains were used in this study: Dyt1ΔE (Dang et 
al., 2005), Gad65::N45GFP (Lopez-Bendito et al., 2004), Ptf1aCre (Kawaguchi et 
al., 2002), Ptf1aCreER (Pan et al., 2013), R26CAG−lox−STOP−tdTomato/+ (Jackson, 
Ai14) (Madisen et al., 2010), and Thy1lox-STOP-YFP (line 15) (Buffelli et al., 2003). 
Experiments conform to the regulatory standards of the Institutional Animal 
Care and Use Committee of Memorial Sloan Kettering Cancer Center. 
2.6.2 Tamoxifen Injections 
Tamoxifen (TM) (T-5648; Sigma-Aldrich) was dissolved in corn oil (C-
8267; Sigma-Aldrich) at a final concentration of 20 mg/ml. TM was 
intraperitoneally injected once into pregnant dams at 9.5 or 12.5 post-coitus, 
and pups were harvested at embryonic day (e)18.5 or postnatal day (p)21. For 
embryo harvest, 80-100 mg/kg TM was administered at both time points. For 
postnatal harvest, 20 mg/kg TM was administered at e9.5, and 100 mg/kg TM 




Immunohistochemistry and in situ hybridization on 12 μm or 20 μm 
thick cryostat sections were performed as previously described (Arber et al., 
1999; Betley et al., 2009) with the following modification: mice were perfused 
by peristaltic pump (World Precision Instruments) with a 2% heparin (Butler-
Schein) normal saline solution flush, followed by room temperature 4% PFA. 
Antibodies were used in 0.3% Triton-X in phosphate buffer saline (PBS) 
with 1% bovine serum albumin (BSA) or 0.1% PBT with 1% BSA. The 
following antibodies were used in this study: rabbit anti-GAD65 (1:8000; Betley 
et al. 2009), mouse anti-GAD67 (1:10,000; Millipore), rabbit anti-GFP (1:1000; 
Invitrogen), rabbit anti-Ptf1a (1:5000; generously provided by C. Wright), 
guinea pig anti-RFP (1:2000; generously provided by N. Betley; Betley et al., 
2013), rabbit anti-RFP (1:1000; Rockland), rabbit anti-Shank1a (1:1000; 
Millipore), rabbit anti-Tor1a (1:600; Millipore), guinea pig anti-vGluT1 
(1:32,000; Betley et al. 2009), and fluorophore-conjugated secondary 
antibodies (Jackson Labs and Molecular Probes). 
In situ hybridization combined with antibody staining was performed as 
described (Ashrafi et al., 2014b). tdTomato or GFP detection in combination 
with in situ hybridization was performed with additional TSA amplification 
(Perkin-Elmer) of the RFP or GFP antibodies with donkey anti-rabbit HRP-
conjugated secondary (1:1000; Millipore). In situ hybridization of Gad1 (Russ 
et al., 2015), Gad2 (Russ et al., 2015), and Klhl14 (generously provided by H. 




2.6.4 Synaptic Quantification 
Synaptic number counts were performed using Leica LASAF software 
plug-in (Version 2.6.0.7266) on z stacks (0.3 μm optical sections) obtained on 
a Leica TCS SP5 confocal. At least three mice per genotype were analyzed 
and ≥ 100 vGluT1ON sensory terminals were counted per animal. Differences 
between wild type and mutant mice were determined using t-test or two-way 
ANOVA. p > 0.05 n.s., p < 0.01 **, p < 0.0001 ****. Data are reported as mean 
± SEM. 
2.6.5 Candidate Screen 
Spinal cords were removed from three p6 Gad65::N45GFP mice, 
embedded in UltraPure L.M.P. agarose (Invitrogen) and vibratome sectioned 
at 300 μm. The dorsal, intermediate and ventral regions were then dissected 
from each section and flash frozen on dry ice. RNA was obtained by trizol 
extraction and run on an Alumina microarray. Gene expression data was 
analyzed using BioConductor suit of tools (www.bioconductor.org) in R 
statistical language (www.r-project.org). The data were normalized using 
standard gcrma function. For each group comparison, differentially expressed 
genes were sought using limma package with a p-value cut-off of 0.05 
(adjusted for multiple hypothesis testing) and fold-changes of 2. Pathway 
analysis was done using the functional annotation tool DAVID 
https://david.ncifcrf.gov/. 
2.6.6 Statistics 
Probability densities of tdTomato-positive (tdTomatoON) cell body 
position were calculated in e18.5 Ptf1aCre; R26tdTomato embryos following TM 
injection at e9.5 and e12.5. Positional coordinates of tdTomatoON cell bodies 
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were obtained using software developed in the laboratory (Russ et al., 2013). 
The positional coordinates were then processed in R statistical language using 
the kde2d function from the MASS package. Further computation and 
graphical display was also performed in R. Student’s t-test or ANOVA was 
used for synaptic quantifications. 
 
2.7 Results  
2.7.1 Screen for motor disease associated markers enriched in the 
intermediate spinal cord 
Disruption of the H-reflex, which is the reflexive activation of muscles 
following electrical stimulation of sensory afferents, is a feature of a number of 
human movement disorders, including dystonia and Parkinson’s disease 
(Nakashima et al., 1989; Panizza et al., 1990; Roberts et al., 1994; Priori et al., 
1995, 2000; Morita et al., 2001). Given the role of presynaptic inhibition in 
modulating the H-reflex (Knikou, 2008), and the known function of spinal 
GABApre interneurons in presynaptically inhibiting proprioceptive sensory 
inputs (Betley et al., 2009; Fink et al., 2014), we sought to better characterize 
the molecular profile of GABApre interneurons with a specific focus on 
markers that are associated with motor disease. 
Based on previous results suggesting GABApre neurons reside in the 
intermediate spinal cord (Jankowska et al., 1981; Hughes et al., 2005; Betley 
et al., 2009), we performed a cDNA microarray screen comparing cDNA 
probes from intermediate spinal cord (I) with those from superficial dorsal (D) 
and ventral (V) domains of p6 Gad65::N45GFP lumbar spinal cord, using GFP 
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expression as a visual marker of dorsal and intermediate domains (Fig. 1A). 
We found 268 genes to be differentially expressed in the intermediate spinal 
cord, of which 61 were greater than two-fold upregulated in the intermediate 
spinal cord compared to both the dorsal and ventral spinal cord (Fig. 1A). This 
subset encodes proteins with diverse molecular functions including DNA 
binding, ion binding, nucleotide binding, receptors, as well as those with 
unknown function (Fig. 1B). 
For this list of 61 genes, we assessed the in situ spinal expression 
patterns in p4 mice in silico Allen Brain Atlas (http://www.brain-map.org/). We 
found 11 candidates to be exclusively expressed in the intermediate spinal 
cord (Fig. 1C). One of these genes was the kelch-like family member protein 
Klhl14, implicated in motor disease due to its direct binding of the dystonia 1 
protein Tor1a (Giles et al., 2009). Tor1a encodes a protein in the ATP-ase 
family that is involved in protein folding and trafficking (Breakefield et al., 2008; 
Charlesworth et al., 2013). A single amino acid mutation in Tor1a, Dyt1ΔE, is 
highly implicated in early-onset generalized dystonia (Ozelius et al., 1997).   
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Figure 2.1: Screen for novel genes expressed in the intermediate spinal 
cord 
(A) To find genes enriched in the intermediate spinal cord, gene expression 
levels were compared between dissected dorsal (D), intermediate (I) and 
ventral (V) spinal cord regions at p6 (see inset). Genes with significant (p < 
0.05) and two fold or greater expression changes (268 genes) are graphed as 
a scatter plot comparing intermediate versus ventral (y-axis) and intermediate 
versus dorsal (x-axis) spinal regions. Genes that are upregulated in the 
intermediate region in both comparisons are in quadrant 1 (Q1, red, 61 
genes), genes that are differentially expressed in both comparisons are in 
quadrant 2, 3, and 4 (Q2, 3, 4, black, 207 genes), and genes that are 
differentially expressed in either comparison are grey (1720 genes). Both 
Gad2 and Klhl14 are upregulated in the intermediate region (Q1). 
 
(B) Functional classification of the 61 genes upregulated in both comparisons 
identified 4 main groups and many of unknown function. 
 
(C) Analyzing in situ hybridization data from the Allen Brain Institute further 
restricted the 61 candidates to 11 genes (including Klhl14) that showed 
specific expression in the intermediate spinal cord.  
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2.7.2 Klhl14 is expressed in intermediate inhibitory interneurons 
Klhl14 has previously been shown to be expressed in the intermediate 
spinal cord (Wildner et al., 2013). We assessed the expression pattern of 
Klhl14 more specifically using in situ hybridization. At late embryonic e18.5 
(Fig. 2A) and early postnatal ages p5 and p10 (Fig. 2B, C), Klhl14 was 
expressed in a restricted domain of the intermediate spinal cord, close to the 
central canal. This restricted expression pattern was maintained throughout 
the rostro-caudal extent of the lumbar spinal cord (Fig. 2D, red arrow). We did 
not detect Klhl14 signal in the dorsal root ganglion (DRG), suggesting that 
Klhl14 is not expressed in sensory neurons (Fig. 2D, black arrow). 
We next asked if Klhl14 was expressed in GABAergic inhibitory 
interneurons. The transcription factor Ptf1a is required for GABAergic 
neurotransmitter fate, and in the absence of Ptf1a, the precursors of spinal 
GABAergic interneurons give rise to excitatory glutamatergic neurons instead 
(Glasgow et al., 2005). In Ptf1a mutant spinal cords (Ptf1aCre/Cre), we observed 
no spinal expression of Klhl14 (Fig. 2E). 
To test whether Klhl14 is expressed in Ptf1a-derived GABAergic 
interneurons, we labeled Ptf1a-derived neurons by intercrossing a Ptf1aCre 
driver line (Kawaguchi et al., 2002) with mice carrying a Thy1YFP fluorescent 
protein reporter line (Buffelli et al., 2003) and performed dual 
immunohistochemistry/in situ hybridization using antibodies against GFP and 
a Klhl14 RNA probe. We found that Klhl14 expression strongly overlapped 
with YFP-expressing Ptf1a-derived neurons in the intermediate spinal cord 
(Fig. 2F). Given the observed absence of Klhl14 expression in Ptf1a mutants,   
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Figure 2.2: Klhl14 expression in spinal inhibitory interneurons 
(A-E) Klhl14 transcript expression at e18.5 (A), p5 (B and D (red arrow)), and 
p10 (C). There is no Klhl14 expression in DRG (D, (black arrow)). Dotted line 
in D depicts midline. Klhl14 expression is absent in e18.5 Ptf1a mutant 
(Ptf1aCre/Cre) spinal cords (E).  
(F) Klhl14 transcript co-expression with fluorescently labeled GFPON (green) 
neurons in the intermediate spinal cord of Ptf1aCre; Thy1YFP mice at p5. 
Scale bars: A, E, 200 μm; B-D, 100 μm; F, 50 μm. 
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we attribute the detection of Klhl14 in neurons that are not YFP-expressing to 
the known mosaic expression of the Thy1YFP allele (Betley et al., 2009). Taken 
together, these results suggest that Klhl14 is specifically expressed in Ptf1a-
derived interneurons of the intermediate spinal cord.  
 
2.7.3 Late but not early Ptf1a expression distinguishes GABApre 
neurons 
We next tested whether we could associate Klhl14 labeling specifically 
with GABApre neurons, the subset of Ptf1a-derived GABAergic spinal 
interneurons that presynaptically inhibit sensory afferents (Hughes et al., 2005; 
Betley et al., 2009). Developmental timing can be harnessed as a tool to study 
subpopulations of cells (Tripodi et al., 2011; Benito-Gonzalez and Alvarez, 
2012). To specifically correlate Klh14 expression with GABApre neurons, we 
asked whether the GABApre neuron domain might be distinguished by specific 
timing of Ptf1a expression. 
In the developing spinal cord, Ptf1a is expressed in postmitotic cells of 
the dI4/dILA precursor domain (Wildner et al., 2006). Ptf1a is expressed 
broadly in neuronal cell bodies throughout the dorsal-intermediate spinal cord 
between the time points of e9.5 and e13.5 (data not shown, Glasgow et al., 
2005; Mizuguchi et al., 2006; Wildner et al., 2006). We first sought to 
recapitulate this broad dorsal expression by generating Ptf1aCre mice carrying 
a tdTomato(tdT)-reporter line (R26CAG-lox-STOP-tdTomato) (Madisen et al., 2010) 
(Fig. 3B). We confirmed that this cross labels GABApre interneurons by 
assessing tdTomato expression in ventral axo-axonic synapses (Fig. 3C) that   
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Figure 2.3: Klhl14 is expressed in GABApre neurons 
(A) Ptf1a expression timeline and tamoxifen (TM) injection paradigm. 
(B) tdTomatoON (red) cells in the dorsal-intermediate spinal cord of Ptf1aCre; 
R26tdTomato mice at e18.5. 
(C) tdTomatoON (red) boutons on vGluT1ON (blue) sensory terminals in the 
ventral horn of p21 Ptf1aCre; R26tdTomato mice. 
(D, E) tdTomatoON (red) boutons on vGluT1ON (blue) sensory terminals co-
express GABApre synaptic markers GAD65 (green, D) and GAD67 (green, E). 
(F) tdTomatoON (red) cells in the dorsal spinal cord of e9.5 TM injected 
Ptf1aCreER; R26tdTomato mice at e18.5. 
(G-I) No ventral tdTomatoON projections in e9.5 TM injected Ptf1aCre; 
R26tdTomato mice at p21. 
(J) tdTomatoON (red) cells in the intermediate spinal cord of e12.5 TM injected 
Ptf1aCreER; R26tdTomato mice at e18.5. 
(K-M) tdTomatoON (red) boutons project into the ventral spinal cord (K) in 
e12.5 TM injected Ptf1aCre; R26tdTomato mice at p21 and express GABApre 
synaptic markers GAD65 (green, L) and GAD67 (green, M). 
(N) At e18.5, Gad2 (blue) expressing Ptf1a-derived cells in e12.5 TM injected 
Ptf1aCreER; R26tdTomato mice settle in the intermediate spinal cord (n = 159, 
three mice). 
(O) At e18.5, Klhl14 (red) expressing Ptf1a-derived cells in e12.5 TM injected 
Ptf1aCreER; R26tdTomato mice settle in the intermediate spinal cord (n = 183, 
three mice). 
(P) Overlay of Gad2 (blue) and Klhl14 (red) expression patterns in late Ptf1a-
derived cells. Scale bars: B, F, J, 50 μm; C-E, G-I, K-M, 2 μm. 
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abut vGluT1-expressing sensory terminals. We further show that these 
tdTomato-expressing synapses on vGluT1 sensory terminals express the 
GABA-synthetic enzyme GAD65 and GAD67, known markers of GABApre 
boutons (Hughes et al., 2005; Betley et al., 2009) (Fig. 3D-E).  
We next assessed whether the timing of Ptf1a expression could be 
used to identify specific subpopulations of Ptf1a-derived interneurons. To 
accomplish this, we used an inducible Ptf1aCreER mouse line (Pan et al., 2013) 
and injected tamoxifen (TM) at different time points (Nguyen et al., 2009) (Fig. 
3A). We found that injecting 100 μg/g TM at e9.5 or e12.5 gave rise to 
fluorescently labeled Ptf1a-derived neurons in distinct domains of the dorsal 
and intermediate spinal cord (Fig. 3F, J). In all Ptf1a-derived cells, labeled 
neurons localized to both the dorsal and intermediate spinal cord (Fig. 3B). TM 
injection at e9.5 predominately labeled neurons localized to superficial layers 
of the dorsal horn (Fig. 3F), while TM injection at e12.5 predominantly labeled 
neurons localized to the intermediate spinal cord (Fig. 3J). This suggests that 
putative GABApre cell bodies in the intermediate spinal cord derive from 
relatively late Ptf1a-expressing precursors, and may be distinguished on this 
basis. 
We next sought to confirm whether these putative GABApre cells are in 
fact GABApre interneurons. We asked whether tdTomatoON terminals, labeled 
via e9.5 or e12.5 TM injections, form axo-axonic contacts on proprioceptive 
terminals in the ventral spinal cord and express typical GABApre markers. We 
found that neurons labeled at e9.5 TM did not project ventrally (Fig. 3G-I). In 
contrast, we found that neurons labeled at e12.5 TM did project ventrally, 
formed contacts on vGluT1ON sensory terminals (Fig. 3K), and expressed the 
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GABApre specific markers GAD65 (Fig. 3L) and GAD67 (Fig. 3M). Thus, TM 
injections into Ptf1aCreER; R26tdTomato mice at e12.5 label GABApre 
interneurons.  
 
2.7.4 Klhl14 is expressed in GABApre neurons 
To determine whether Klhl14 labels GABApre neurons, we performed 
TM injections at e9.5 and e12.5 into Ptf1aCreER; R26tdTomato mice and 
performed dual immunohistochemistry/in situ hybridization staining using anti-
RFP antibody and a Klhl14 RNA probe. We found that in e12.5 TM injected 
mice tdTomatoON cells in the intermediate spinal cord co-express Klhl14 (Fig. 
3O). We performed analogous immunohistochemistry/in situ labeling for RFP 
and GAD2 transcript, the primary molecular marker for GABApre neurons, and 
similarly saw strong colocalization (Fig. 3N). In these experiments, the 
domains of coexpression of Klhl14 and tdTomato and GAD2 and tdTomato 
were highly similar (Fig. 3P), confirming the strong correlation of their 
expression in GABApre neurons. 
 
2.7.5 GABApre bouton formation is disrupted in Tor1a mutant mice 
We next assessed whether Klhl14 has a functional role of in GABApre 
neurons. Little is known about the function of Klhl14, other than that it is a 
cofactor of the dystonia 1 protein Tor1a, which it binds in the endoplasmic 
reticulum of neurons (Giles et al., 2009). Deletion of a single glutamic acid 
residue in the C-terminal region of Tor1a (ΔE) severely disrupts binding to 
Klhl14 (Ozelius et al., 1997; Giles et al., 2009), and in humans, this mutation 
  
48 
causes early-onset generalized torsion dystonia, characterized by sustained 
muscle contractions involving both agonist and antagonist muscles (Ozelius et 
al., 1997; Breakefield et al., 2008). We assessed the spinal expression of 
Tor1a in mouse and found that it was expressed in proprioceptive sensory 
neurons in the DRG (data not shown), as well as in the spinal cord, including 
the majority of Ptf1a-derived interneurons in the intermediate spinal cord (Fig. 
4A, B). These data confirm that both Klhl14 and its binding partner Tor1a are 
expressed in Ptf1a-derived inhibitory interneurons in the intermediate spinal 
cord. 
Given the localization of Klhl14 and Tor1a to putative GABApre 
neurons, and given that individuals with dystonia often show deficits in the 
proprioceptive-mediated H-reflex (Nakashima et al., 1989; Panizza et al., 
1990; Priori et al., 1995), we sought to assess the function of Klhl14-Tor1a 
binding in GABApre interneuron circuitry. To do this, we used Dyt1ΔE mice 
(Dang et al., 2005), which have a single amino acid deletion in Tor1a that 
mirrors the human mutation and disrupts Tor1a binding to Klhl14. We used 
male mice heterozygous for the mutant allele, which are viable and display 
motor abnormalities such as deficits in beam walking and hyperactivity at six 
months of age (Dang et al., 2005). 
Dyt1ΔE mice have been shown to have deficits in synaptic vesicle 
recycling and synaptic protein stabilization in neural tissues such as the 
hippocampus and cerebellum (Kim et al., 2010; Granata et al., 2011). Because 
Tor1a is expressed in proprioceptive neurons of the DRG, we first assessed 
sensory-motor connectivity in Dyt1ΔE mice. We assessed proprioceptive   
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Figure 2.4: Abnormal GABApre synaptic organization in Dyt1ΔE mice 
(A) tdTomatoON (red) neurons in the intermediate spinal cord of Ptf1aCre; 
R26tdTomato mice. 
(B) Tor1a (green) expression in tdTomatoON (red) neurons in Ptf1aCre; 
R26tdTomato mice at p5. 
(C) Schematic showing sensory neuron (SN) terminals express vGluT1 and 
are adjacent to Shank1a on motor neurons (MN). GABApre boutons express 
GAD65 and GAD67. 
(D, E) vGluT1ON (blue) sensory terminals are adjacent to Shank1a (red) in wt 
(D) and Dyt1ΔE mice (E) at p21. 
(F, G) Sensory terminal density (F, wt: 1.18 ± 0.12, n = 570 terminals, three 
mice; Dyt1ΔE: 0.97 ± 0.18, n = 469 terminals, three mice; t-test, p = 0.4 n.s.) 
and volume (G, wt: 1.69 ± 0.1, n = 570 terminals, three mice; Dyt1ΔE: 1.46 ± 
0.11, n = 469 terminals, three mice; t-test, p = 0.11 n.s.) are normal in Dyt1ΔE 
mutant mice compared to wt controls. 
(H, I) tdTomatoON (red) cells in Ptf1aCre; R26tdTomato control (H) and Ptf1aCre; 
R26tdTomato; Dyt1ΔE mice (I). 
(J) The number of putative GABApre neurons is normal in Dyt1ΔE mice (wt: 
24.5 ± 1.4, three mice; Dyt1ΔE: 25.4 ± 1, three mice; t-test, p = 0.66 n.s.) 
(K-M) Fewer GAD65ON (green)/GAD67ON (red) GABApre boutons (yellow) on 
vGluT1ON (blue) sensory terminals in p21 Dyt1ΔE mutant mice (L, L’) 
compared to wt mice (K, K’). Compiled average number of GAD65ON/GAD67ON 
GABApre boutons on vGluT1ON sensory terminals is reduced by 20% in 
Dyt1ΔE mutant mice (M, wt: 2.30 ± 0.11, n = 335 terminals, three mice; 
Dyt1ΔE: 1.87 ± 0.1, n = 304 terminals, three mice; ANOVA, p < 0.01 **). 
(N-P) Fewer GAD65ON (green)/GAD67ON (red) GABApre boutons (yellow) on 
vGluT1ON (blue) sensory terminals in 6 month old Dyt1ΔE mutant mice (O, O’) 
compared to wt mice (N, N’). Compiled average number of 
GAD65ON/GAD67ON GABApre boutons on vGluT1ON sensory terminals is 
reduced by 26% in Dyt1ΔE mutant mice (P, wt: 2.49 ± 0.12, n = 344 terminals, 
three mice; Dyt1ΔE: 1.82 ± 0.1, n = 330 terminals, three mice; ANOVA, p < 
0.0001 ****). Scale bars: A, B, 50 μm; D, E, K-O’, 2 μm; H, I, 200 μm.





afferent terminal number and density on motor neurons to verify the normal 
differentiation of sensory-motor synapses. Using vGluT1 to label sensory 
terminals (Fig. 4C), we found that the vGluT1ON sensory terminal number and 
density were comparable between wild type and Dyt1ΔE mice (Fig. 4F, G; p = 
0.4 and p = 0.11). The alignment of post-synaptic density marker, Shank1a, 
with vGlut1ON sensory terminals (Fig. 4D, E) was also unchanged. Thus, 
proprioceptive afferent terminals are normal in Dyt1ΔE mice as compared to 
wild type mice. 
We next analyzed GABApre circuitry by first testing whether the number 
of GABApre neurons is altered in Dyt1ΔE mice. To label putative GABApre 
neurons, we intercrossed the Dyt1ΔE mice with Ptf1aCre; R26tdTomato mice, and 
assessed whether the number of GABApre neurons remains the same (Fig. 
4H, I). We saw no difference in the number of tdTomatoON putative GABApre 
neurons in the intermediate region in Dyt1ΔE compared to wild type mice (Fig. 
4J; p = 0.66). We next assessed whether GABApre synaptic organization was 
affected in Dyt1ΔE mice. We used the co-expression of the two GABApre 
bouton markers, GAD65 and GAD67 (GAD65ON/GAD67ON) on vGluT1ON 
sensory terminals to label GABApre boutons (Fig. 4C). We quantified the 
number of GAD65ON/GAD67ON boutons at p21 when locomotor circuits have 
finished developing (Fig. 4K-I’), as well as at 6 months (Fig. 4N-O’) when a 
behavioral motor defect is first observed in Dyt1ΔE mice (Dang et al., 2005). 
We found a 20% and 26% reduction in the number of GAD65ON/GAD67ON 
boutons on vGluT1ON sensory terminals in Dyt1ΔE mice as compared to wild 
type controls at p21 (Fig. 4M; ANOVA, p < 0.01 **) and 6 months, respectively 
(Fig. 4P; ANOVA, p < 0.0001 ****). We observed no increase of either 
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GAD65ON or GAD67ON boutons, suggesting there is a joint loss of both 
markers (data not shown). These findings suggest that Klhl14-Tor1a binding in 




Spinal interneurons are essential for modulating locomotor behavior, 
but their potential involvement in many motor disease states is unclear. 
Deficits in presynaptic inhibition of proprioceptive sensory afferents have been 
observed in human patients with movement disorders or focal motor deficits 
(Nakashima et al., 1989; Panizza et al., 1990; Priori et al., 2000), however, 
suggesting a potential role for GABApre interneurons in the pathophysiology of 
such disorders. 
In this work, we demonstrate that despite the remarkable diversity of 
interneuron subtypes in the central nervous system, an approach using 
knowledge of molecular markers combined with developmental lineage 
analysis can be used to isolate and identify specific subclasses of spinal 
interneurons. Thus identified, further transcriptional screening approaches can 
identify new subclass-specific molecular markers that can begin to relate 
specific neuronal microcircuits to genetic disorders of nervous system 
functioning. As proof of this principle, we have identified the kelch-like family 
member protein Klhl14 as specifically expressed in spinal GABApre 
interneurons, and show that mutation of a hereditary dystonia-related gene, 
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the Klhl14 binding partner Tor1a, at a site that disrupts binding to Klhl14, leads 
to measurable deficits in GABApre-sensory neuron connectivity. 
 
2.8.1 Molecular characterization and transcriptional screening of 
GABApre neurons 
Ptf1a is expressed in postmitotic cells of the dI4/dILA precursor domain 
(Wildner et al., 2006). In our prior published work (Betley et al., 2009), we 
characterized synapses deriving from Ptf1a-expressing (Ptf1aON) interneurons 
and inferred two different interneuron populations: (i) one that forms direct axo-
axonic connections with proprioceptive sensory terminals in the intermediate 
and ventral spinal cord (GABApre) (Hughes et al., 2005; Betley et al., 2009) 
and (ii) one that forms axo-axonic contacts in the dorsal spinal cord. We 
further showed that the interneuronal synapses formed dorsally can be 
distinguished from those in the intermediate and ventral spinal cord in that the 
dorsal terminals are peptidergic and express the glycine transporter (GlyT)2, 
while the ventral GABApre boutons are neither glycinergic nor peptidergic, and 
express GAD65, GAD67 and Syt1 (Betley et al., 2009). Our molecular 
anatomic work thus supports the long standing hypothesis based on 
electrophysiological evidence that a dorsal interneuron population 
presynaptically inhibits cutaneous sensory terminals in the dorsal spinal cord, 
while an intermediate population projects ventrally and contacts proprioceptive 




In this work, we confirm that the cell bodies of ventrally projecting 
GABApre interneurons are located in the intermediate spinal cord, and further 
demonstrate that their segregation to this region reflects specific 
developmental timing. In the spinal cord, interneuronal diversification begins 
embryonically with discrete progenitor domains giving rise to specific cell 
populations. One progenitor domain, known as dI4 during a first wave of 
neurogenesis, and dILA during a second wave of neurogenesis, gives rise to 
all Ptf1a-derived dorsal inhibitory interneurons, including GABApre neurons. 
Our molecular labeling and developmental timing studies identify the specific 
GABApre subclass of dorsal inhibitory interneurons as selectively localized to 
the intermediate spinal cord and emerging from dILA during the second wave 
of neurogenesis. This suggests a strong correlation between developmental 
timing, cell position and target selection and supports previous findings that 
showed premotor interneuron segregate by timing of neurogenesis (Tripodi et 
al., 2011). 
 
2.8.2 Tor1a function in GABApre circuitry 
Tor1a has been shown to play a role at synapses in synaptic vesicle 
recycling (Granata et al., 2008, 2011). In mouse cerebellum, there is a 
decrease in inhibitory synaptic contacts on Purkinje cells in both Tor1a+/- mice 
and mice carrying the human Dyt1ΔE mutation, suggesting that GABAergic 
synaptogenesis is compromised in the presence of mutant Tor1a (Sharma, 
2005; Vanni et al., 2015). Our study further supports a neurodevelopmental 
role for Tor1a in synaptogenesis. In mouse spinal cord, we find that GABApre 
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bouton formation is compromised in Dyt1ΔE mice, in that there is a decrease 
in GABApre contacts on sensory terminals. 
 
2.8.3 Where is Tor1a functioning to affect GABApre synaptogenesis?  
Human studies postulate that observed deficits in H-reflex are due to 
affected descending control of spinal circuitry. Specifically, basal ganglia 
dysfunction has been associated with symptoms of dystonia (Breakefield et 
al., 2008; Pappas et al., 2015). While there is no direct input from the basal 
ganglia to the spinal cord, basal ganglia project to the cortex and corticospinal 
tract (CST) projections have been shown to directly contact putative GABApre 
neurons (Russ et al., 2013). Tor1a is expressed in the cortex (Shashidharan et 
al., 2000), however, it is unknown whether it is specifically expressed in CST 
neurons. If Tor1a is expressed in CST neurons, then mutated Tor1a, Dyt1ΔE 
may be causing aberrant CST input on GABApre cell bodies. Interestingly, in a 
mouse model of perinatal stroke in which there is a gross loss of descending 
CST inputs to GABApre cell bodies, GABApre GAD65 levels are decreased, 
while GABApre bouton number remains the same (Russ et al., 2013). This 
suggests against the possibility that the Dyt1ΔE mutation is affecting cortical 
circuits. 
 
Although Klhl14 is expressed in intermediate neurons of the dorsal 
spinal cord and not in sensory neurons of the DRG, Tor1a is expressed in the 
DRG and a subset of proprioceptive sensory neurons (data not shown). The 
GABApre-sensory synapse phenotype of Dyt1ΔE mice may thus reflect 
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dysfunction of Tor1a in sensory proprioceptors. We believe this is unlikely for 
two reasons: the first is that we observe no change in the number of synaptic 
contacts by sensory proprioceptors on motor neurons; the second is that the 
Dyt1ΔE mutation specifically affects binding of Klhl14 to Tor1a, and that Klhl14 
is specifically expressed in GABApre interneurons. We thus interpret that the 
Dyt1ΔE GABApre-sensory synapse phenotype reflects cell-autonomous 
functioning of Tor1a in GABApre interneurons.  
 
2.8.4 Tor1a in GABAergic synaptogenesis 
How loss of Tor1a contributes to the decreased number of GABApre-
sensory synapses remains an outstanding question. The Dyt1ΔE mutation’s 
disruption of Tor1a to Klhl14 binding may provide clues. While little is known 
about Klhl14, several studies have focused on other members of the Kelch-like 
protein family members. Namely, Klhl1 has been identified as an actin-binding 
protein that is expressed in the axons and dendrites of neurons and glia in the 
nervous system, modulates voltage-gated calcium channels (Nemes et al., 
2000), and regulates neurite and cellular process extension (Seng et al., 2006; 
Jiang et al., 2007). Knockdown of Klhl1 in rat hippocampal cultures results in 
decreased number of excitatory and inhibitory synapses (Perissinotti et al., 
2015). The loss of synapses seen in Dyt1ΔE mice hints that Klhl14 may have 
a similar role to Klhl1. The specific synaptic function of Tor1a may further 
reflect its association with Klhl14, and Tor1a thus may be considered to have a 
role at the interface of synaptic membrane recycling and local cytoskeletal 
dynamics. Given that the Dyt1ΔE phenotype of decreased GABApre-sensory 
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synapse number is strikingly similar to that seen following deletion of Ig-
superfamily adhesion molecules expressed in GABApre interneurons or their 
sensory afferent partners (Ashrafi et al., 2014b) it is tempting to speculate that 
adhesive signaling may be affected by loss of Tor1a-Klhl14 binding.
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Chapter 3 
 
Developmental Timing and Candidate Genes of GABApre neurons 
 
3.1 Introduction 
  Our finding that the GABApre neuron population can be further 
restricted by developmental timing and novel GABApre candidate gene 
expression may be used to better identify and study GABApre circuitry. 
 
3.2 Identity of early Ptf1a-derived interneurons 
 Inhibitory interneurons in the dorsal horn consist of several 
subpopulations of cells that express a wide variety of factors, such as 
neuropeptide Y (NPY), enkephalin (pENK), and glycine (Todd, 1996; Betley et 
al., 2009; Polgar et al., 2013). Functionally, these cells modulate cutaneous 
sensory modalities such as nociception (pain) and mechanosensation (touch) 
(Abraira and Ginty, 2013). Previous EM studies revealed presynaptic inhibition 
on cutaneous afferents in the dorsal horn (Réthelyi et al., 1982) by analyzing 
the presence of GABAergic and glycinergic axo-axonic contacts on sensory 
afferent terminals (Watson et al., 2002; Watson, 2003). This suggests that 
besides GABApre neurons that form boutons on proprioceptive terminals in 
the ventral horn, there is also a dorsal population of presynaptic inhibitory 
interneurons that form boutons on cutaneous terminals. While both 
populations are Ptf1a-derived and form presynaptic contacts, one population 
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targets proprioceptive terminals, and the other targets cutaneous terminals 
(Betley et al., 2009).  
Using differential timing of birth to label neurons, subpopulations of 
premotor interneurons were successfully segregated (Tripodi et al., 2011; 
Benito-Gonzalez and Alvarez, 2012). Since there are at least two 
subpopulations of presynaptic inhibitory interneurons that are Ptf1a-derived, 
those that contact cutaneous afferents and those that contact proprioceptive 
afferents, can we also use timing of Ptf1a expression to segregate 
subpopulations of presynaptic interneurons? To segregate subpopulations of 
presynaptic inhibitory interneurons, we used timed TM injections at an early 
time point of e9.5 and a late time point of e12.5 in Ptf1aCreER; R26tdTomato mice. 
We found that the majority of the early-labeled population had cell bodies 
positioned in the dorsal spinal cord. By analyzing the expression of GABAergic 
synaptic markers in all early-labeled synapses in the dorsal horn, we found 
that the majority of dorsal horn synapses labeled in e9.5 TM injected mice 
expressed GAD67 (Fig. 3.1). Analyzing the expression of peptidergic markers 
such as NPY and pENK in these early-labeled synapses was difficult due to 
inefficient antibody labeling in the dorsal horn. 
 The majority of labeled synapses analyzed in the dorsal horn of 
early TM injected mice expressed GAD67, and we asked what were the 
targets of these labeled synapses. Since GABAergic contacts are found on 
cutaneous afferents (Todd, 1996; Watson, 2003; Betley et al., 2009), we 
analyzed whether early-labeled synapses in the dorsal horn were targeting 
cutaneous afferents. To analyze the targeting of dorsal inhibitory interneurons 




Figure 3.1: Synaptic identity of early e9.5 TM labeled synapses 
(A) e9.5 TM labeled cells reside in the dorsal horn where they form GABAergic 
synapses labeled with GAD65 and GAD67. Scale bar: 2 μm. 
(B) Diagram of neurons in the dorsal horn also forming contacts in the dorsal 
horn, in contrast to GABApre neurons which reside in the intermediate spinal 
cord but form contacts in the ventral horn. 
(C) The majority of e9.5 TM labeled dorsal synapses analyzed expressed 
GAD67 (70%). e12.5 TM labeled dorsal synapses also expressed GAD67 
(76%), while labeled ventral synapses expressed both GAD65 and GAD67 
(77%).
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conjunction with CTb labeling of cutaneous afferents. We found tdTomato 
labeled presynaptic contacts on cutaneous afferents in the dorsal horn of e9.5 
TM injected mice, although we were unable to determine the neurotransmitter 
expression in these presynaptic contacts due to the extremely low frequency 
of tdTomato labeled contacts on CTb labeled afferents (Fig. 3.2). A major 
impediment to TM labeling at e9.5 was the embryo lethality caused by TM 
injections into pregnant dams at such an early time point in development. As a 
result the dose of TM had to be dropped which resulted in fewer tdTomato 
labeled cells with e9.5 TM injections compared to e12.5. Hence, the 
incidences of e9.5 TM labeled synapses adjacent to CTb labeled cutaneous 
afferents were extremely rare. However, our data nevertheless suggests that 
early TM injection labels cutaneous presynaptic neurons, while only late TM 
injection labeled GABApre neurons. 
 
3.3 Novel GABApre interneuron genes 
In locomotor circuits, interneuronal diversity is essential in controlling 
specific aspects of movement. Genetic screens identified subpopulations of 
interneurons with distinct gene expression patterns that localize in highly 
unique positions along the rostrocaudal and mediolateral axes of the spinal 
cord (Bikoff et al., 2016). While Ptf1a is a marker for dorsal inhibitory 
interneurons, there is no specific marker of GABApre neurons. To identify 
distinct and novel genes expressed in GABApre neurons, we conducted a 
microarray screen for genes specifically upregulated in the intermediate spinal 
cord where GABApre cell bodies are thought to reside (Jankowska et al., 




Figure 3.2: Targeting of early and late labeled Ptf1a-derived neurons 
(A, B) Early e9.5 TM labeled neurons form contacts (red) onto CTb labeled 
(green) cutaneous afferents. 
(C, D) Some late e12.5 TM labeled neurons (red) also form cutaneous 
contacts (green). 
(E, F) No e9.5 TM labeled neurons project to the ventral horn and form 
contacts on vGluT1 labeled proprioceptive terminals (green). 
(G, H) Only e12.5 TM labeled neurons (red) project to the ventral horn and 




the Allen Brain Atlas expression database to confirm any intermediate 
enriched candidate genes and identified Klhl14, which we localized to 
GABApre neurons, and 10 other candidates that had intermediate restricted 
expression in the spinal cord. The other intermediate restricted genes are 
ankyrin repeat and SOCS box containing 4 (Asb4), CART prepropeptide 
(Cartpt), coiled-coil domain containing 109b (Ccdc109b), cadherin 7, type 2 
(Cdh7), crystallin mu (Crym), neurogenic differentiation 1 (Neurod1), 
nephronectin (Npnt), retinoic aid receptor, beta (Rarb), shisa family member 3 
(Shisa3), and transcription factor AP-2 beta (Tfap2β). These genes serve a 
variety of cellular functions that include DNA binding, ion binding, and 
hormone binding. In the next section I would like to focus on two genes, Crym 
and Tfap2β that have been previously identified by other candidate screens in 
the lab and have exclusive intermediate gene expression.  
Crym is a hormone binding protein with enzymatic function that was first 
discovered in the eye lens of marsupials where it protects against oxidative 
stress (Wistow and Kim, 1991). It is expressed in striatal neurons in the brain, 
where it binds thyroid hormone and has a neuroprotective effect from 
Huntington’s disease (Francelle et al., 2015). Previous work in the lab has 
analyzed Crym expression in the spinal cord, and found it expressed at e18.5, 
p5 and turned off by p30 in the adult mouse (Fig. 3.3, Lathan McCall and Julia 
Kaltschmidt, unpublished). Crym is expressed in inhibitory interneurons, 
revealed by the fact that Crym expression is abolished in spinal cords null for 
Ptf1a (Ptf1aCre/Cre) (Fig. 3.3, Lathan McCall and Julia Kaltschmidt, 
unpublished). To further localize Crym to GABApre neurons, Crym expression 
would be evaluated in Ptf1a-derived neurons in the intermediate spinal cord of 
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Ptf1aCre; R26tdTomato mice, since Ptf1a expression is fairly unique to GABApre 
neurons in the intermediate region (Fink et al., 2014). Also, given that we 
found that late TM labeled Ptf1a-derived cells in the intermediate spinal cord 
are likely GABApre neurons, we would analyze Crym expression in late Ptf1a-
derived cells in the intermediate spinal cord to determine whether Crym is 
expressed in GABApre neurons.  
To further study Crym expression and function, a CrymCre line is 
available (http://www.informatics.jax.org/allele/MGI:5632478) that when 
crossed to a conditional fluorescent reporter mouse line, would permanently 
label Crym expression in cells and synapses. This will further reveal whether 
Crym expressing cells are GABApre neurons, and form boutons on sensory 
afferent terminals, and whether Crym is expressed in all GABApre neurons or 
a subset. If Crym is expressed in GABApre neurons, Crym conditional 
knockout mouse lines may be used to analyze the consequence of loss of 
Crym expression in GABApre neurons and their circuitry. Loss of Crym 
expression in GABApre neurons may result in changes in GABApre 
development and circuitry due to oxidative stress. 
The other identified candidate gene that was also previously studied in 
the lab due to its intermediate gene expression is Tfap2β. Tfap2β is part of the 
AP-2 family of transcription factors, which form dimers to bind to DNA 
sequences. In the retina, transcription factor Tfap2β has been identified to be 
downstream of Ptf1a and important for the differentiation of amacrine cells 
during development (Jin et al., 2015). In the spinal cord, Tfap2β is also 
downstream of Ptf1a and expressed during embryonic and early postnatal 
development. Previous work in the lab has shown Tfap2β to be expressed at 
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e18.5 and p5 (Lathan McCall and Julia Kaltschmidt , unpublished, Wildner et 
al., 2013). Tfap2β expression was also identified to be Ptf1a dependent, and 
expressed in inhibitory interneurons (Fig. 3.3). To localize Tfap2β expression 
in GABApre neurons, previous work in the lab scored co-expression of GFP 
positive cells with Tfap2β in Gad65::N45GFP. 40% of GFP positive cells 
expressed Tfap2β  at p6 (Laura McCormick, Lathan McCall and Julia 
Kaltschmidt, unpublished). Analysis of GFP co-expression with Ptf1a in 
Ptf1aCre; R26LacZ mice revealed that while all GABApre terminals expressed 
GFP, there is extra expression of GFP in the dorsal spinal cord of 
Gad65::N45GFP mice (Betley et al., 2009). While this experiment provided the 
first insight into whether Tfap2β is expressed in GABApre neurons, to further 
restrict Tfap2β expression in GABApre neurons, we analyzed Tfap2β 
expression in late Ptf1a-derived cells in the intermediate spinal cord. 
We first analyzed Tfap2β expression in Ptf1a-derived cells in Ptf1aCre; 
R26tdTomato mice and found that 37% of RFP labeled cells co-expressed 
Tfap2β in the intermediate spinal cord. To further assess Tfap2β expression 
as it relates to early and late Ptf1a-derived cells, we used early (e9.5) and late 
(e12.5) timed TM injections in Ptf1aCreER; R26tdTomato mice. Tfap2β expression 
was identified in tdTomato labeled cells in the intermediate spinal cord in both 
early and late TM injected Ptf1aCreER; R26tdTomato mice (Fig. 3.4). Taken 
together, these data show that Tfap2β is likely expressed in GABApre 
neurons, in addition to other subtypes of interneurons. To further study Tfap2β 
expression and function in GABApre neurons, transgenic mouse lines such as 
a cre line or conditional KO line would need to be created. Using a mutant 





Figure 3.3: Tfap2β and Crym expression 
(A) Tfap2β expression in e18.5 control spinal cord. 
(B) No Tfap2β expression in e18.5 spinal cord null for Ptf1a. 
(C) Crym expression in e17.5 control spinal cord. Lathan McCall and Julia 
Kaltschmidt, unpublished. 
(D) No Crym expression in e17.5 spinal cord null for Ptf1a. Lathan McCall and 




Figure 3.4: Timing of Tfap2β expression in Ptf1a-derived cells 
(A, B) Density map of cell body distribution in Ptf1aCreER; R26tdTomato e9.5 TM 
injected tissue at e18.5 (A). Density map of cell body distribution in Ptf1aCreER; 
R26tdTomato e12.5 TM injected tissue at e18.5 (B). 
(C) Subtraction map of e9.5 TM density map (A) and e12.5 TM density map 
(B), with green areas showing more e9.5 TM density and purple areas 
showing more 12.5 TM density. White areas show even density distribution 
between e9.5 TM map and e12.5 TM map. Purple box in the intermediate 
spinal cord is uniquely e12.5 TM density distribution, where GABApre cell 
bodies may be enriched. 
(D) There is three-fold enrichment for intermediate cell body positioning within 
the box in e12.5 TM injected tissue compared to e9.5 TM injected tissue. 
(E, F) Tfap2β is expressed in the intermediate spinal cord (E). This expression 
is enriched with 75% of RFP and Tfap2β double-labeled cells in the box in 
Ptf1aCreER; R26tdTomato e12.5 TM injected tissue (F). 
(G) Overall percent of Ptf1a-derived cells labeled with RFP that express 
Tfap2β in early and late TM injected tissue. There are RFP/Tfap2β double 
labeled cells in e9.5 TM injected tissue (30%).
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changing fates or failing to develop properly due to the fact that Tfap2β is a 
transcription factor, participating in the developmental programming of cells. 
Taken together, the GABApre population can be further restricted by 
late Ptf1a expression, while some early Ptf1a expressing cells seem to be 
GABAergic and contact cutaneous afferents. Furthermore, GABApre 
candidate genes, Crym and Tfap2β are promising due to their dependence on 
Ptf1a expression, and their exclusive expression in the intermediate spinal 
cord. Further studies may be conducted to localize their expression in 
GABApre neurons. 
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Chapter 4 
Concluding Remarks and Future Directions 
4.1 Introduction 
My thesis work investigated the expression of Klhl14 in GABApre 
neurons, and the link between GABApre neurons and motor disease in the 
spinal cord. GABApre neurons exert presynaptic inhibition on proprioceptive 
sensory afferents in the sensory-motor circuit, and deficits in presynaptic 
inhibition have been demonstrated in many different motor diseases such as 
dystonia and Parkinson’s disease. However, the contribution of GABApre 
neurons to motor disease is largely unstudied. This has been especially 
difficult to study due to the lack of specific markers of GABApre neurons that 
could be used to target them. We set out to identify novel GABApre genes with 
a focus on those that may be involved in a motor disease. We performed a 
microarray screen at p6 when GABApre boutons are first formed (Betley et al., 
2009), and compared upregulated genes in the intermediate spinal cord to 
those expressed in the dorsal and ventral horn. We thereby identified Klhl14 to 
be highly expressed in the intermediate region. To further evaluate to what 
extent Klhl14 expression is restricted to GABApre neurons, we used our 
finding that GABApre neurons are a late Ptf1a-derived population, and 
identified Klhl14 expression to localize to late Ptf1a-derived GABApre neurons. 
Klhl14 binds Tor1a, which is implicated in dystonia. In a mouse mutant for 
Tor1a, Dyt1ΔE, in which Klhl14 and Tor1a binding is disrupted but not entirely 
abolished, we identified a 20% reduction in the number of GABApre boutons 
on sensory afferent terminals when compared to controls. The molecular 
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mechanisms that lead to GABApre bouton loss in Dyt1ΔE mutant mice, as 
well as the functional consequences of this loss remain unresolved. In this 
chapter we will address future directions and experiments to further our 
developmental and genetic understanding of GABApre interneurons and how 
their circuitry is disrupted due to the Dyt1ΔE mutation.  
 
4.2 Timing of neurogenesis of Ptf1a-derived interneurons 
 Dorsal interneurons are born from six dorsal progenitor domains in the 
developing mouse embryo (Caspary and Anderson, 2003; Helms and 
Johnson, 2003). There are two waves of neurogenesis with early 
neurogenesis occurring at e10-e11.5, and late neurogenesis occurring at e12-
e14.5. Dorsal inhibitory interneurons are born in the dI4 domain during early 
neurogenesis, and in the dILA domain during late neurogenesis (Gross et al., 
2002; Müller et al., 2002).  
 Dorsal inhibitory interneurons from both the dI4 domain as well as the 
dILA domain express the transcription factor Ptf1a (Glasgow et al., 2005; 
Wildner et al., 2013). Ptf1a expression is post-mitotic and temporally restricted 
during mouse development, turning on at e10.5 and turning off after e13.5 
(Fig. 4.1, Glasgow et al., 2005; Mizuguchi et al., 2006). Ptf1a expression turns 
on after neurogenesis, but the exact correlation between timing of 
neurogenesis of a neuron and timing of Ptf1a expression is unknown. For 
example, it is not known when a neuron, born at e10, expresses Ptf1a after its 
birth, and whether that timing is exactly the same for each neuron. To verify 
that late Ptf1a-derived neurons are also later born cells, we would use  
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Figure 4.1: Timeline of Ptf1a expression 
(A-D) In situ hybridization of Ptf1a expression in mouse developing spinal cord 
from e10.5 to e13.5. No expression is seen before or after these time points. 
Scale bar: 100 μm. 
(E-H) Antibody labeling of Ptf1a expression with Lmx1b (marker for dI5 and 
dILB). There is no colabeling between Ptf1a and Lmx1b. Ptf1a is expressed in 
dI4 at e10.5 and e11.5, above dI5. Ptf1a expression expands in dILA, which 
intermingles with dILB in a salt and pepper fashion at e12.5 and e13.5. Scale 
bars: 50 μm. 
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bromodeoxyuridine (BrdU) to assign timing of birth to Ptf1a-derived cells. 
Since BrdU labels dividing cells, we would inject BrdU at e9.5 or e12.5 into 
pregnant R26tdTomato dams that were crossed with Ptf1aCre animals so that the 
pups would have all Ptf1a-derived cells fluorescently labeled. BrdU and RFP 
double-labeled cells would enable us to map cell body positioning to timing of 
birth of Ptf1a-derived neurons. If both early and late BrdU injections labeled 
cells in a similar cell distribution to our TM labeling at the same time points, it 
would correlate timing of birth with timing of Ptf1a expression (Fig. 4.2). This 
would confirm that late born Ptf1a-derived cells in dILA, some of which are 
GABApre neurons, also express Ptf1a late. If we do not see similar cell 
distributions between timed BrdU labeling and timed TM labeling, it would 
suggest that the timing of birth and the subsequent timing of Ptf1a expression 
are not correlated, and that different cells could be expressing Ptf1a at varying 
time points after they are born. 
 
4.3 Disrupted Klhl14 and Tor1a binding due to Dyt1ΔE mutation 
Identifying genetic markers of GABApre neurons may further our 
understanding of their role in motor disease. Our analysis of a mutant mouse 
for dystonia, Dyt1ΔE, revealed a loss of GABApre bouton number on sensory 
afferent terminals. The Dyt1ΔE mutation results in disrupted binding between 
the mutant Tor1a protein and its cofactor Klhl14 (Giles et al., 2009). Klhl14 is 
highly conserved amongst humans and rats with 99% similarity of amino acid 
identity (Giles et al., 2009). Tor1a protein is broadly distributed, although there 




Figure 4.2: Using BrdU to assign timing of birth to Ptf1a-derived neurons 
(A) BrdU is injected into pregnant Ptf1aCre; R26tdTomato dams at e9.5 and e12.5 
when our TM injections were also done. 
(B) We expect e9.5 BrdU injections to label RFP-positive cells in the dorsal 
spinal cord, suggesting that early born Ptf1a-derived cells settle in the dorsal 
horn, confirming our e9.5 TM labeling. 
(C) We expect e12.5 BrdU injections to label RFP-positive cells in the 
intermediate spinal cord as well as in the dorsal horn. This suggests that only 
late born Ptf1a-derived neurons have intermediate cell body positioning and 
are likely GABApre neurons, confirming our e12.5 TM labeling.
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(Breakefield et al., 2008). Within a cell, Tor1a is localized to the nuclear 
envelope (NE) (Goodchild et al., 2005), endoplasmic reticulum (ER) (Callan et 
al., 2007), and it has been found in synaptic terminals (Granata et al., 2008). 
Klhl14 and Tor1a codistribute in neural tissues. For example, colocalization of 
Klhl14 and Tor1a were found in the ER of human-derived cells in cell culture 
(Giles et al., 2009). While the Dyt1ΔE mutation significantly reduces binding 
between Klhl14 and Tor1a, this mutation does not completely abolish it (Giles 
et al., 2009).  
 Synaptic abnormalities have been observed both in vitro and in vivo 
due to the Dyt1ΔE mutation. In vivo studies using Dyt1ΔE mutant mice 
revealed decreased probability of synaptic vesicle release in hippocampal 
slices, supporting the work in cell culture showing deficits in synaptic vesicle 
recycling. Furthermore, there was a significant reduction in the frequency of 
sEPSCs, signaling a presynaptic release deficit. There was no change in 
miniature (m)EPSCs, which are action-potential independent (Yokoi et al., 
2013). This suggests that an action-potential dependent presynaptic release 
deficit is present in Dyt1ΔE mutants. 
   In vitro studies using cell culture showed that Tor1a binds snapin 
(Granata et al., 2008), an important protein for vesicle exocytosis by improving 
the interaction of the SNARE complex with Syt1 (Ilardi et al., 1999). The Dyt1
ΔE mutation causes the accumulation of Syt1 on the plasma membrane at 
synapses and hindered synaptic vesicle recycling overall (Granata et al., 2008, 
2011).  
 Since the Dyt1ΔE mutation has been shown to cause the accumulation 
of Syt1 at the cell membrane of synapses, changes in Syt1 levels in GABApre 
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boutons may be indicative of deficits in synaptic machinery that may lead to 
synapse loss or dysfunction. Tor1a may play a role stabilizing synaptic 
machinery, and mutant Tor1a may destabilize synapses causing them to not 
form or to retract (Granata et al., 2008, 2011). To evaluate changes in Syt1 
levels in GABApre boutons in Dyt1ΔE mice, we will intercross Ptf1aCre with 
R26tdTomato mice on the Dyt1ΔE background to fluorescently label GABApre 
boutons, and colabel them with RFP and Syt1 to measure Syt1 intensity levels 
on vGluT1 terminals in wt and Dyt1ΔE mutant mice. As a control, due to the 
fact that GAD67 is cytoplasmic and not associated with synaptic machinery, 
we will also analyze the protein levels of GAD67 at the synapse. We expect to 
see no change in GAD67 levels in GABApre boutons in Dyt1ΔE mice (in 
collaboration with Jarret Weinrich). 
 
4.4 Analysis of a Klhl14 mutant 
 The previous studies on synaptic abnormalities observed in the Dyt1Δ
E mutation have been solely focused on Tor1a. Recent work has revealed that 
Tor1a interacts with Klhl14, and that the Dyt1ΔE mutation disrupts Tor1a-
Klhl14 binding (Giles et al., 2009). While very little is known about the function 
of Klhl14, other members of the kelch-like family proteins have been found to 
bind actin and play a role in synaptogenesis (Perissinotti et al., 2015). 
Therefore to gain a better understanding of the function of Klhl14 protein and 
its expression in neurons, a classic approach would be to label Klhl14-
expressing cells and their processes and study the consequences of a loss-of-
function of Klhl14 in GABApre interneurons.  
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  To label Klhl14-expressing cells and their processes, mouse genetics 
may to be used. To permanently label Klhl14-expressing cells, a mouse line in 
which Klhl14 drives cre expression, Klhl14Cre would permanently label all 
Klhl14-expressing cells and their synapses when crossed to a fluorescent 
reporter line such as R26tdtomato. The presence of fluorescently labeled boutons 
on sensory terminals in the ventral horn along with their co-expression of 
GABApre markers, such as GAD65, GAD67, and Syt1 would verify that 
fluorescently labeled Klhl14-expressing cells are GABApre neurons (Fig. 
4.3A). Additionally this experiment will tell us whether Klhl14 is expressed in all 
GABApre neurons, or just a subset, and whether its expression is exclusively 
in GABApre neurons or also in other inhibitory spinal interneurons.  
To evaluate the role of Klhl14 in neural circuitry and GABApre neurons 
with a conditional KO mouse line of Klhl14, we would generate a floxed Klhl14 
mutant and intercross it with the Ptf1aCre mouse line, which expresses cre in 
all Ptf1a-derived cells. Based on the restricted expression of Klhl14, we predict 
that this conditional Klhl14 KO mouse may highly target GABApre cells (Fig. 
4.3B). By analyzing GABApre bouton circuitry in these mutant mice, we would 
evaluate whether the synaptic deficits observed in Dyt1ΔE mutants are solely 
due to mutated Tor1a or due to interrupted Tor1a-Klhl14 binding. Since there 
are no sensory-motor deficits observed in Dyt1ΔE mice, the changes in 
GABApre circuitry are likely due exclusively to GABApre dysfunction. If we see 
a similar 20% or greater loss of GABApre boutons at p21 in Klhl14 mutant 
mice, it would reveal that Tor1a-Klhl14 binding is necessary for GABApre 
bouton formation. If no change in GABApre bouton number is seen in these 
Klhl14 mutants, it is likely that GABApre bouton loss is exclusively due to  
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Figure 4.3: Mouse lines to better study Klhl14 expression and function 
(A) Klhl14Cre mice intercrossed with R26tdTomato mice have Klhl14 expressing 
neurons and projections labeled. Some if not all of these cells may be 
GABApre neurons. 
(B) Conditional Klhl14 KO reporter mice intercrossed with Ptf1aCre mice are 
null for Klhl14 in Ptf1a-derived cells, which are labeled with a fluorescent 
protein reporter such as GFP. 
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Tor1a dysfunction in Dyt1ΔE mice. If Klhl14 mutants do exhibit changes in 
GABApre circuitry, behavioral testing such as studying gain control would be 
conducted, which is elaborated further in a later section of this thesis. 
 
4.5 Descending pathways in dystonia 
 Most of the research conducted on understanding dystonia is focused 
on neural circuit dysfunction in the brain, which investigators believe to be the 
source of dystonic symptoms. Tor1a is highly expressed throughout the CNS, 
including the cerebral cortex, basal ganglia, and cerebellum (Shashidharan et 
al., 2000; Granata et al., 2009; Puglisi et al., 2013). Especially high expression 
of Tor1a is observed in dopaminergic neurons in the substantia nigra in 
humans, suggesting a link between dopamine signaling and Dyt1 mutations 
(Farrell et al., 2009; Sciamanna et al., 2012; Pappas et al., 2015). 
Furthermore, some forms of dystonia are dopa responsive and treatment with 
L-dopa help ameliorate symptoms of the disorder (Breakefield et al., 2008), 
revealing that abnormal levels of dopamine in the striatum can result in the 
symptoms of dystonia. 
 There have been many fewer studies examining spinal circuitry 
dysfunction in dystonia, and these studies in the spinal cord were restricted to 
H-reflex testing in human patients of dystonia. Nakashima et al. (1989) found 
increased H-reflexes due to decreased presynaptic inhibition in human 
patients with dystonia compared to controls, and postulated that this could be 
due to basal ganglia dysfunction, which results in disrupted descending control 
of spinal interneurons (Nakashima et al., 1989). The basal ganglia does not 
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form direct contacts in the spinal cord (Nelson and Kreitzer, 2014), but the 
basal ganglia does project to the cortex and the corticospinal tract (CST). 
Dysfunctional basal ganglia input could be affecting CST neurons, which have 
been shown to directly contact putative GABApre neurons (Russ et al., 2013). 
Since Tor1a is expressed in the cortex (Shashidharan et al., 2000), and CST 
neurons reside in the cortex and project to the spinal cord (Welniarz et al., 
2015), Tor1a could be expressed in CST neurons that provide input to 
GABApre neurons.  
To localize Tor1a in CST neurons, novel viral tracing techniques may 
be used to retrogradely label CST neurons from their contacts on GABApre 
neurons in the spinal cord. Basaldella et al. (2015) used viral tracing 
technology to identify projection neurons from the spinal cord to the brain. By 
conducting intraspinal injections of G-protein deficient rabies viruses encoding 
fluorescent protein markers (Basaldella et al., 2015) into the intermediate 
spinal cord where GABApre cell bodies reside, we would retrogradely label 
CST neurons in Ptf1aCre; R26tdTomato mice. By labeling the precise cortical 
neurons that contact GABApre cell bodies, we would identify whether these 
cortical neurons express Tor1a. Furthermore carrying out this technique would 
also serve as a means to evaluate potential changes in connectivity between 
labeled CST neurons and labeled GABApre neurons in Ptf1aCre; R26tdTomato 
mice on wt and Dyt1ΔE background.  
In Dyt1ΔE mice, mutant Tor1a in CST neurons could be affecting their 
input on GABApre neurons. To visualize CST input, Emx1GFP mice would be 
used, in which Emx1 drives GFP expression in all cortical neurons (Hantman 
and Jessell, 2011). To determine whether GABApre neurons have disrupted 
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CST input in Dyt1ΔE mice, Emx1GFP mice would be crossed with Ptf1aCre; 
R26tdTomato mice on the Dyt1ΔE background to analyze CST projections and 
contacts on putative GABApre cell bodies in the intermediate spinal cord 
(Hantman and Jessell, 2011). Previous work has shown that disrupted CST 
input on putative GABApre cell bodies in a mouse model for perinatal stroke 
showed no loss in GABApre bouton number (Russ et al., 2013), so our loss of 
GABApre bouton phenotype may be due exclusively to GABApre dysfunction. 
 Recently, the translational relevance of certain Dyt1ΔE mouse models 
of dystonia has come into question. Dyt1ΔE mutant mice seem to lack 
dystonic symptoms such as persistent co-contraction of muscles and 
involuntary twisting movements. Instead, these mice exhibit other abnormal 
movements such as deficits in beam walking and hyperactivity (Dang et al., 
2006). Due to the fact that Dyt1ΔE is a loss-of-function mutation, recent work 
has studied a conditional Tor1a KO in the brain as a mouse model for 
dystonia. Deletion of Tor1a in cholinergic and GABAergic progenitors in the 
forebrain and striatum caused motor abnormalities in mice during juvenile CNS 
maturation, which better represented the symptoms exhibited in human 
patients of dystonia (Pappas et al., 2015). In these mutant mice, abnormal 
motor behaviors of twisting and limb clasping were observed, and worsened 
as the mice matured. Antimuscarinic drugs were effective at mitigating these 
motor defects, suggesting abnormal cholinergic signaling in these mutant 
mice. Furthermore, GABAergic cell number was not affected in the striatum, 
but cholinergic cell number was deficient, due to cholinergic cell death 
(Pappas et al., 2015). While the cholinergic system was well studied in this 
mutant mouse, the contributions of Tor1a loss in GABAergic cells was not 
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elucidated beyond a cell number analysis that showed no cell death. 
Furthermore, any changes in overall neural circuitry of inhibitory neurons was 
not addressed, even though other studies have suggested that GABAergic 
synaptogenesis is impaired in cerebellum in other mouse models for dystonia 
(Vanni et al., 2015). 
 If the conditional Tor1a KO mutant described in Pappas et al. (2015) is 
a more accurate mouse model of dystonia, we would evaluate deficits in 
presynaptic inhibition in this line. To evaluate potential changes in GABApre 
circuitry, Tor1a conditional KO mice would be crossed to Ptf1aCre mice in order 
to selectively KO Tor1a in Ptf1a-derived cells and GABApre neurons. We 
would then check for proper GABApre bouton formation.  
 
4.6 Behavioral testing and function 
 While studying the changes in neural circuitry deficits in mouse models 
of dystonia may provide insight into the causes of the disorder, behavioral 
testing would verify the translational relevance of mouse models of dystonia. 
Although there has been some work reconciling the motor symptoms observed 
in human patients with relevant mouse models (Pappas et al., 2015), further 
behavioral testing of presynaptic inhibition and measuring H-reflex offer 
additional insights. In human patients of dystonia, H-reflex testing has shown 
decreased presynaptic inhibition (Nakashima et al., 1989; Panizza et al., 
1990). To test whether deficits in presynaptic inhibition may be observed in 
mouse models of dystonia several mouse lines such as the conditional Tor1a 
KO mouse as well as the Dyt1ΔE mice should be tested for changes in H-
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reflex. A greater H-reflex observed in mice with conditional Tor1a KO in 
forebrain as described in Pappas et al., 2015 that exhibits dystonic symptoms, 
may further suggest that deficits in presynaptic inhibition are associated with 
dystonia. This study may also reveal potential deficits in presynaptic inhibition 
that could be due to GABApre neuron dysfunction in either forelimb or hindlimb 
in these mutant mice, since both limbs can be affected in human patients of 
dystonia (Breakefield et al., 2008). In Dyt1ΔE mice, H-reflex testing may also 
reveal deficits in presynaptic inhibition due to loss of GABApre boutons, which 
would result in increased H-reflex in Dyt1ΔE mice compared to wt.  
 Presynaptic inhibition serves as a method of providing gain control on 
sensory feedback (Fink et al., 2014), and deficits in presynaptic inhibition may 
result in abnormal gain control. Measuring the H-reflex in human studies of 
dystonia has been conducted in the forearm (Nakashima et al., 1989; Priori et 
al., 1995), while deficits in gain control in mice while executing skilled 
movement have been observed in the forelimb (Fink et al., 2014). To test for 
fine motor deficits due to gain control, mouse models of dystonia such as the 
conditional Tor1a KO and Dyt1ΔE mice would be subjected to a targeted 
reaching assay as described in Fink et al. (2014). Deficits in gain control in 
these mouse models may provide a further link between GABApre neuron 
dysfunction that may also be due to CST defects, and the symptoms of 
dystonia.  
 Finally, electrophysiological studies may contribute to a better 
understanding of GABApre circuit dysfunction in mouse models of dystonia. 
To analyze deficits in presynaptic inhibition in mouse models for dystonia, we 
would record from dorsal roots to measure changes in presynaptic inhibition 
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and PAD. If GABApre neurons in Tor1a conditional KO mice or Dyt1ΔE mice 
are dysfunctional we may see more PAD, which along with potential changes 
in H-reflex, may provide further evidence that GABApre neurons and changes 
in presynaptic inhibition may mediate symptoms associated with dystonia.  
 
4.7 Concluding remarks 
 My thesis work identified enriched genes in the intermediate spinal 
cord, and evaluated a potential link between GABApre neurons and dystonia. 
Using the timeline of transcription factor Ptf1a expression, I showed that 
GABApre neurons are late Ptf1a-derived cells, and that GABApre neurons 
express Klhl14 and its cofactor, Tor1a. Klhl14 and Tor1a directly bind, and this 
binding is disrupted in the Dyt1ΔE mutated form of Tor1a, which has been 
implicated in dystonia. I demonstrated that mice carrying this Dyt1ΔE 
mutation displayed a decrease in GABApre bouton number compared to wt 
mice. Although no studies have evaluated GABApre dysfunction in mediating 
the symptoms of dystonia, in human patients of dystonia, measuring changes 
in the H-reflex revealed deficits in presynaptic inhibition. Given our finding of a 
loss of GABApre bouton number, these deficits in presynaptic inhibition could 
be due to disrupted GABApre circuitry in the Dyt1ΔE mutation. Taken 
together, these data suggest a link between GABApre neurons and dystonia.  
 Dystonia is widely believed to be due to circuit disorder because of the 
absence of any neurodegeneration, and in this chapter I have discussed 
current efforts as well as future directions that would provide insight into how 
GABApre neurons may be affected in dystonia. The generation of Klhl14 
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mutant mice may help to confirm Klhl14 expression in GABApre neurons, and 
to further understand the role of Klhl14 in GABApre bouton formation and 
differentiation. Moreover, testing of H-reflex in mouse models of dystonia 
would provide greater insight into the role and weight of presynaptic inhibition 
in dystonia and even other motor diseases. 
Ultimately, interneurons are an incredibly heterogeneous population of 
cells, and interneuron dysfunction has been linked to numerous nervous 
system disorders. Understanding the development, circuitry, and function of 
specific subpopulations of interneurons will provide a greater understanding of 
how they participate in human disease. The final goal is the potential to 
develop better therapeutics to cure neural pathologies. By identifying and 
understanding the underlying cause of these disorders, we will be able to 
develop therapeutics to alleviate or even cure them.
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